UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: ' | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | Y | Z
Number of items: 641.

'

't Hoen, PAC; van der Wees, CGC; Aartsma-Rus, A; Turk, R; Goyenvalle, A; Danos, O; Garcia, L; ... van Deutekom, JCT; + view all (2006) Gene expression profiling to monitor therapeutic and adverse effects of antisense therapies for Duchenne muscular dystrophy. Pharmacogenomics , 7 (3) pp. 281-297. 10.2217/14622416.7.3.281.

A

Ajzensztejn, D; Hegde, V; Lee, SM; (2006) Tumour lysis syndrome following treatment with standard second-line docetaxel for non-small cell lung cancer. Journal of Clinical Oncology , 24 (15) pp. 2389-2391.

Al-Mahdawi, S; Pinto, RM; Varshney, D; Lawrence, L; Lowrie, MB; Hughes, S; Webster, Z; ... Pook, MA; + view all (2006) GAA repeat expansion mutation mouse models of Friedreich's ataxia exhibit oxidative stress leading to progressive neuronal cardiac pathology. Genomics , 88 (5) pp. 580-590.

Al-Shahrour, F; Minguez, P; Trraga, J; Montaner, D; Alloza, E; Vaquerizas, JM; Conde, L; ... Dopazo, J; + view all (2006) BABELOMICS: a systems biology perspective in the functional annotation of genome-scale experiments. Nucleic Acids Res , 34 (Web Serv) W472-W476. 10.1093/nar/gkl172.

Alonzi, R; Hoskin, P; (2006) Functional imaging in clinical oncology: Magnetic resonance imaging- and computerised tomography-based techniques. CLINICAL ONCOLOGY , 18 (7) pp. 555-570.

Amary, MFC; Lam, L; Bernardi, FDC; Michelagnoli, M; Berisha, F; Diss, T; Flanagan, AM; (2006) SYT-SSX fusion transcript can be detected in a very high proportion of formalin-fixed paraffin-embedded synovial sarcomas using conventional, real-time RT-PCR and FISH. In: (Proceedings) 190th Meeting of the Pathological-Society-of-Great-Britain-and-Ireland. (pp. p. 26). WILEY-BLACKWELL

Ancliff, PJ; Blundell, MP; Cory, GO; Calle, Y; Worth, A; Kempski, H; Burns, S; ... Thrasher, AJ; + view all (2006) Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia. Blood , 108 (7) pp. 2182-2189. 10.1182/blood-2006-01-010249.

Ancliff, PJ; Blundell, MP; Cory, GO; Calle, Y; Worth, A; Kempski, H; Burns, S; ... Thrasher, AJ; + view all (2006) Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia. BLOOD , 108 (7) 2182 - 2189.

Arkenau, HT; (2006) 42nd annual meeting of the American society of clinical oncology, Atlanta, USA, 2006: Adjuvant treatment for colon and rectal cancer. Advances in Gastrointestinal Cancers , 4 (2) pp. 21-22.

Arnould, S; Spanswick, VJ; Macpherson, JS; Hartley, JA; Thurston, DE; Jodrell, DI; Guichard, SM; (2006) Time-dependent cytotoxicity induced by SJG-136 (NSC 694501): influence of the rate of interstrand cross-link formation on DNA damage signaling. Mol Cancer Ther , 5 (6) pp. 1602-1609. 10.1158/1535-7163.MCT-06-0018.

Arnould, S; Spanswick, VJ; Macpherson, JS; Hartley, JA; Thurston, DE; Jodrell, DI; Guichard, SM; (2006) Time-dependent cytotoxicity induced by SJU-136 (NSC 694501): influence of the rate of interstrand cross-link formation on DNA damage signaling. MOL CANCER THER , 5 (6) 1602 - 1609. 10.1158/1535-7163.MCT-06-0018.

Austin, S; Cohen, H; (2006) Antiphospholipid syndrome. Medicine , 34 (11) pp. 472-475. 10.1053/j.mpmed.2006.08.012.

Austin, SK; Lawrie, AS; Starke, RD; Scully, M; Machin, SJ; Cohen, H; Mackie, IJ; (2006) ADAMTS13 antibodies in patients with antiphospholipid antibodies. Presented at: 46th Annual Scientific Meeting of the British-Society-for-Haematology, Edinburgh, SCOTLAND.

Austin, SK; Lawrie, AS; Starke, RD; Scully, M; Machin, SJ; Cohen, H; Mackie, IJ; (2006) ADAMTS13 antibodies in patients with antiphospholipid antibodies. In: (pp. p. 94).

Austin, SK; Starke, RD; Purdy, G; Lawrie, AS; Machin, SJ; Mackie, IJ; (2006) High affinity autoantibodies to ADAMTS13 in the antiphospholipid syndrome. In: BLOOD. (pp. 424A - 424A). AMER SOC HEMATOLOGY

Ayaru, L; Pereira, SP; Meyer, T; Davidson, BR; Burroughs, AK; Williams, R; Behboudi, S; (2006) Alpha-fetoprotein specific CD4(+) T cell responses are unmasked during transarterial embolisation in hepatocellular carcinoma. In: GUT. (pp. A24 - A24). B M J PUBLISHING GROUP

Ayaru, L; Pereira, SP; Meyer, T; Davidson, BR; Burroughs, AK; Williams, R; Behboudi, S; (2006) Alpha-fetoprotein specific CD4+ T cell responses are unmasked during transarterial embolisation in hepatocellular carcinoma. In: JOURNAL OF HEPATOLOGY. (pp. S11 - S11). ELSEVIER SCIENCE BV

B

Bates, AW; (2006) Dr Kahn's museum: obscene anatomy in Victorian London. J ROY SOC MED , 99 (12) 618 - 624.

Bates, AW; (2006) The worm, the demon and the virgin: the medieval theories on extraordinary generation: a study on the relations between theology, natural philosophy and medicine. MEDICAL HISTORY , 50 (3) pp. 410-411. Gold open access

Batten, P; Sarathchandra, P; Antoniw, JW; Tay, SS; Lowdell, MW; Taylor, PM; Yacoub, MH; (2006) Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: Relevance to tissue engineering human heart valves. TISSUE ENG , 12 (8) 2263 - 2273.

Baum, M; Hackshaw, A; Houghton, J; Rutqvist, L; Fornander, T; Nordenskjold, B; Nicolucci, A; (2006) Adjuvant goserelin in premenopausal patients with early breast cancer: results from the ‘Zoladex’ in premenopausal patients (ZIPP) trial. European Journal of Cancer , 42 pp. 895-904.

Beck, M; Cox, TM; Gal, A; Mehta, AB; (2006) Lysosomal Diseases, Natural Course, Pathophysiology and Therapy. [Book]. (Vol.96, su). Blackwell

Beck, S; (2006) Epigenetics - The missing link between genetics, disease and the environment. TOXICOL LETT , 164 S18 - S19. 10.1016/j.toxlet.2006.06.042.

Begent, R; (2006) Developing Integrated Informatics Platform for Cancer Research. In: Nagl, S, (ed.) Cancer Bioinformatics: From Therapy Design to Treatment. (pp. 45-55). John Wiley & Sons: Chichester.

Behranwala, KA; Agarwal, T; El-Sharkawi, D; Shorvon, D; Chang, A; (2006) Laparoscopic resection of mucinous cystadenoma of appendix - A careful decision. SURG LAPARO ENDO PER , 16 (5) 347 - 348.

Bellodi, C; Kindle, K; Bernassola, F; Cossarizza, A; Dinsdale, D; Melino, G; Heery, D; (2006) A cytoplasmic PML mutant inhibits p53 function. CELL CYCLE , 5 (22) 2688 - 2692.

Bellodi, C; Kindle, K; Bernassola, F; Dinsdale, D; Cossarizza, A; Melino, G; Heery, D; (2006) Cytoplasmic Function of Mutant Promyelocytic Leukemia (PML) and PML-Retinoic Acid Receptor-alpha. J BIOL CHEM , 281 (20) 14465 - 14473. 10.1074/jbc.M600457200. Gold open access

Bellodi, C; Kindle, K; Bernassola, F; Dinsdale, D; Cossarizza, A; Melino, G; Heery, D; (2006) Cytoplasmic function of mutant PML and PML-RARalpha. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 27 - 27). BLACKWELL PUBLISHING

Bellodi, C; Kindle, K; Bernassola, F; Dinsdale, D; Cossarizza, A; Melino, G; Heery, D; (2006) Role of cytoplasmic forms of PML and PML-RAR alpha in the response to therapy. In: TOXICOLOGY. (pp. 48 - 49). ELSEVIER IRELAND LTD

Benjamin, R; Davidoff, AM; Singh, N; Mcintosh, J; Khwaja, A; Streck, C; Ng, C; ... Nathwani, AC; + view all (2006) Therapeutic efficacy of interferon-beta in a xenograft model of acute myeloid leukaemia. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 62 - 63). BLACKWELL PUBLISHING

Benyo, Z; Gille, A; Bennett, CL; Clausen, BE; Offermanns, S; (2006) Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cells. MOLECULAR PHARMACOLOGY , 70 (6) pp. 1844-1849. 10.1124/mol.106.030833.

Beresford, M; Sanghera, B; Wong, WL; Makris, A; (2006) Imaging of primary breast cancer with F-18-fluorodeoxythymidine PET-CT reveals heterogeneity of proliferation throughout the tumour. SPRINGER, 233 SPRING STREET, NEW YORK, NY 10013 USA

Beresford, MJ; Burcombe, R; Ah-See, ML; Stott, D; Makris, A; (2006) Pre-treatment haemoglobin levels and the prediction of response to neoadjuvant chemotherapy in breast cancer. CLINICAL ONCOLOGY , 18 (6) pp. 453-458.

Beresford, MJ; Chin, Y; Burcombe, Y; Ah-See, M; Makris, A; (2006) Clinical response assessment after 2 cycles of neoadjuvant chemotherapy for primary breast cancer fails to predict for final clinical response, but does predict for pathological complete response. In: (pp. 44S-44S).

Beresford, MJ; Harris, AL; Ah-See, M; Daley, F; Padhani, AR; Makris, A; (2006) The relationship of the neo-angiogenic marker, endoglin, with response to neoadjuvant chemotherapy in breast cancer. BRITISH JOURNAL OF CANCER , 95 (12) pp. 1683-1688.

Beresford, MJ; Padhani, AP; Taylor, NJ; Ah-See, M-L; Stirling, JJ; Makris, A; d'Arcy, JA; (2006) Inter- and intraobserver variability in the evaluation of dynamic breast cancer MRI. Journal of Magnetic Resonance Imaging , 24 (6) pp. 1316-1325. 10.1002/jmri.20768.

Beresford, MJ; Wilson, GD; Makris, A; (2006) Measuring proliferation in breast cancer: practicalities and applications. Breast Cancer Research , 8 (6)

Bergamaschi, D; Samuels, Y; Sullivan, A; Zvelebil, M; Breyssens, H; Bisso, A; Del Sal, G; ... Lu, X; + view all (2006) iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72 polymorphic p53. NATURE GENETICS , 38 (10) pp. 1133-1141. 10.1038/ng1879.

Bergamaschi, D; Samuels, Y; Sullivan, A; Zvelebil, M; Breyssens, H; Bisso, A; Del Sal, G; ... Lu, X; + view all (2006) iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53. Nature Genetics , 38 (10) pp. 1133-1141. 10.1038/ng1879.

Betticher, DC; Martinelli, G; Radford, JA; Kaufmann, M; Dyer, MJS; Kaiser, U; Aulitzky, WE; ... Linch, DC; + view all (2006) Sequential high dose chemotherapy as initial treatment for aggressive sub-types of Non-Hodgkin Lymphoma: results of the international randomized phase III trial (MISTRAL). ANN ONCOL , 17 (10) 1546 - 1552. 10.1093/annonc/mdl153.

Beyan, H; Rakyana, V; Hawa, MI; Browne, P; Beck, S; Leslie, DRD; (2006) Epigenetic methylation of type 1 diabetes susceptibility genes. In: DIABETES. (pp. A545 - A545). AMER DIABETES ASSOC

Bielack, S; Sydes, M; Butterfass-Bahloul, T; Anninga, J; Benninger-Doring, G; Calaminus, G; Dhooge, KC; ... Bernstein, M; + view all (2006) Successful multinational implementation of the European and American Osteosarcoma study EURAMOS-1 within the European Science Foundation's ECT-EUROCORES scheme. In:

Bilancio, A; Okkenhaug, K; Camps, M; Emery, JL; Ruckle, T; Rommel, C; Vanhaesebroeck, B; (2006) Key role of the p110 delta isoforrn of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110 delta function in B cells. BLOOD , 107 (2) pp. 642-650. 10.1182/blood.2005-07-3041.

Billottet, C; Grandage, VL; Gale, RE; Quattropani, A; Rommel, C; Vanhaesebroeck, B; Khwaja, A; (2006) A selective inhibitor of the p110 delta isoform of PI 3-kinase inhibits AML cell proliferation and survival and increases the cytotoxic effects of VP16. ONCOGENE , 25 (50) 6648 - 6659. 10.1038/sj.onc.1209670.

Birney, E; Andrews, D; Caccamo, M; Chen, Y; Clarke, L; Coates, G; Cox, T; ... Hubbard, TJP; + view all (2006) Ensembl 2006. NUCLEIC ACIDS RESEARCH , 34 D556-D561. 10.1093/nar/gkj133.

Birney, E; Andrews, D; Caccamo, M; Chen, Y; Clarke, L; Coates, G; Cox, T; ... Hubbard, TJ; + view all (2006) Ensembl 2006. Nucleic acids research. , 34 (Database)

Bishton, MJ; Lush, R; Russell, NH; Shaw, BE; Haynes, AP; (2006) Ifosphamide, etoposide and epirubicin (IVE) is an effective combined salvage and peripheral blood stem cell mobilisation regimen for transplant-eligible patients with lymphoma. In: BLOOD. (pp. 688A - 688A). AMER SOC HEMATOLOGY

Blay, J; Le Cesne, A; Whelan, J; Van Oosterom, A; Ray-Coquard, I; Judson, L; Hogendorn, P; ... Van Glabbeke, M; + view all (2006) Gefitinib in second line treatment of metastatic or locally advanced synovial sarcoma expressing HER1: A phase II trial of EORTC Soft Tissue and Bone Sarcoma Group. In: (pp. 9517-).

Blay, J; Le Cesne, A; Whelan, J; Van Oosterom, A; Ray-Coquard, I; Judson, L; Hogendorn, P; ... Van Glabbeke, M; + view all (2006) Gefitinib in second line treatment of metastatic or locally advanced synovial sarcoma expressing HER1: A phase II trial of EORTC Soft Tissue and Bone Sarcoma Group. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 524S - 524S). AMER SOC CLINICAL ONCOLOGY

Bloor, AJC; Ahmed, O; Dimpoulou, M; Fielding, AK; Chakraverty, R; Parker, AN; Liakopoulou, E; ... Kottaridis, P; + view all (2006) Reduced intensity allogeneic stem cell transplantation in patients with myelofibrosis. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 13 - 13). BLACKWELL PUBLISHING

Bloor, AJC; Mackinnon, S; (2006) Cerebral tuberculosis post stem cell transplant. Eur J Haematol , 77 (5) 456-. 10.1111/j.1600-0609.2006.00718.x.

Boone, JJM; Hochhauser, D; Hartley, JA; (2006) Modulation of the repair of cisplatin-induced DNA interstrand crosslinks by trastuzumab. In: EJC SUPPL. (pp. 151 - 151). PERGAMON-ELSEVIER SCIENCE LTD

Bose, F; Fugazza, C; Casalgrandi, M; Capelli, A; Cunningham, JM; Zhao, Q; Jane, SM; ... Ronchi, A; + view all (2006) Functional interaction of CP2 with GATA-1 in the regulation of dythroid promoters. MOLECULAR AND CELLULAR BIOLOGY , 26 (10) pp. 3942-3954. 10.1128/MCB.26.10.3942-3954.2006.

Boshoff, C; (2006) The biology of cancer. NATURE , 444 (7119) 549 - 549. 10.1038/444549a.

Bourhis, J; Overgaard, J; Audry, H; Ang, KK; Saunders, M; Bernier, J; Horiot, JC; ... Pignon, JP; + view all (2006) Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet. , 368 (9538) pp. 843-854. 10.1016/S0140-6736(06)69121-6.

Bowen, D; Hyslop, A; Keenan, N; Groves, M; Culligan, D; Johnson, P; Shaw, A; ... Cavill, I; + view all (2006) Predicting erythroid response to recombinant erythropoietin plus granulocyte colony-stimulating factor therapy following a single subcutaneous bolus in patients with myelodysplasia. HAEMATOL-HEMATOL J , 91 (5) 709 - 710. Gold open access

Bower, M; Gazzard, B; Mandalia, S; Newsom-Davis, T; Thirlwell, C; Dhillon, T; (2006) A prognostic index for systemic AIDS-related non-hodgkin lymphoma treated in the era of highly active antiretroviral therapy (vol 143, pg 265, 2005). ANN INTERN MED , 144 (8) 620 - 620.

Bridgewater, JA; Floore, A; Warmoes, MO; Veer Van't, L; (2006) Can gene expression microarray (GEM) provide a diagnosis in cases of carcinoma of unknown primary? J Clin Oncol , 24 (18_suppl) 20117-.

Brissault, B; Kichler, A; Leborgne, C; Danos, O; Cheradame, H; Gau, J; Auvray, L; (2006) Synthesis, characterization, and gene transfer application of poly(ethylene glycol-b-ethylenimine) with high molar mass polyamine block. Biomacromolecules , 7 (10) pp. 2863-2870. 10.1021/bm060499a.

Brissault, B; Leborgne, C; Guis, C; Danos, O; Cheradame, H; Kichler, A; (2006) Linear topology confers in vivo gene transfer activity to polyethylenimines. Bioconjug Chem , 17 (3) pp. 759-765. 10.1021/bc050287v.

Brooks, S; Daley, F; Johns, P; Brandner, S; Short, SC; (2006) Pescadillo and CYP1B1: Novel metabolic targets in glioma. In: RADIOTHERAPY AND ONCOLOGY. (pp. S72 - S73). ELSEVIER IRELAND LTD

Buchmueller, K; Bailey, S; Matthews, D; Register, J; Bruce, CD; O'Hare, C; Hartley, J; ... Lee, M; + view all (2006) Molecular recognition of polyamides with DNA: A study on the strong binding of f-ImPyIm to its cognate DNA, ACGCGT. In: (pp. 678-).

Buchmueller, KL; Bailey, SL; Matthews, DA; Taherbhai, ZT; Register, JK; Davis, ZS; Bruce, CD; ... Lee, M; + view all (2006) Physical and structural basis for the strong interactions of the -ImPy- central pairing motif in the polyamide f-ImPyIm. BIOCHEMISTRY-US , 45 (45) 13551 - 13565. 10.1021/bi061245c.

Buffa, FM; Bentzen, SM; Atasoy, BM; Daley, FM; Richman, PI; Dische, S; Wilson, GD; (2006) The response of head and neck tumours to radiotherapy may be influenced by the interaction between cell proliferation and vascularization. In: (Proceedings) 3rd International Conference on Translational Research and Pre-Clinical Strategies in Radiation Oncology. (pp. S65-S66). ELSEVIER IRELAND LTD

Burckbuchler, V; Wintgens, V; Lecomte, S; Percot, A; Leborgne, C; Danos, O; Kichler, A; (2006) DNA compaction into new DNA vectors based on cyclodextrin polymer: surface enhanced Raman spectroscopy characterization. Biopolymers , 81 (5) pp. 360-370. 10.1002/bip.20428.

Burcombe, R; Wilson, GW; Dowsett, M; Khan, I; Richman, PI; Daley, F; Detre, S; (2006) Evaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancer. Breast Cancer Research , 8 (3) R31-. 10.1186/bcr1508.

Burton, C; Linch, D; Hoskin, P; Milligan, D; Dyer, MJS; Hancock, B; Mouncey, P; ... Cunningham, D; + view all (2006) A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma. BRITISH JOURNAL OF CANCER , 94 (6) pp. 806-813.

Burton, C; Linch, D; Hoskin, P; Milligan, D; Dyer, MJS; Hancock, B; Mouncey, P; ... Cunningham, D; + view all (2006) A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma. Br J Cancer , 94 (6) pp. 806-813. 10.1038/sj.bjc.6602975.

Butcher, LM; Kennedy, JK; Plomin, R; (2006) Generalist genes and cognitive neuroscience. Curr.Opin.Neurobiol. , 16 (2) pp. 145-151. 10.1016/j.conb.2006.03.004.

C

Cannon, M; Cesarman, E; Boshoff, C; (2006) KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2. BLOOD , 107 (1) 277 - 284. 10.1182/blood-2005-06-2350. Gold open access

Cappellini, MD; Cohen, A; Piga, A; Bejaoui, M; Perrone, S; Agaoglu, L; Aydinok, Y; ... Alberti, D; + view all (2006) A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. BLOOD , 107 (9) 3455 - 3462. 10.1182/blood-2005-08-3430.

Cappellini, MD; Cohen, A; Piga, A; Bejaoui, M; Perrotta, S; Agaoglu, L; Aydinok, Y; ... Alberti, D; + view all (2006) A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. Blood , 107 (9) pp. 3455-3462. 10.1182/blood-2005-08-3430.

Cappellini, MD; Giardina, P; Porter, J; Coates, T; Della Porta, MG; Siegel, J; Glimm, E; ... Cappellini, MD; + view all (2006) Long-term safety and tolerability of the once-daily, oral iron chelator deferasirox (Exjade (R), ICL670) in patients with transfusional iron overload. In: BLOOD. (pp. 501A - 501A). AMER SOC HEMATOLOGY

Cardigan, R; Lawrie, A; Mackie, I; Williamson, L; (2006) Effect of overnight 4 degrees C storage of whole blood on von Willebrand factor: reply. TRANSFUSION , 46 (6) 1059 - 1060.

Carmo, M; Faria, TQ; Falk, H; Coroadinha, AS; Teixeira, M; Merten, O-W; Gény-Fiamma, C; ... Cruz, PE; + view all (2006) Relationship between retroviral vector membrane and vector stability. J Gen Virol , 87 (Pt 5) pp. 1349-1356. 10.1099/vir.0.81302-0.

Carnell, DM; Smith, RE; Daley, FM; Saunders, MI; Bentzen, SM; Hoskin, PJ; (2006) An immunohistochemical assessment of hypoxia in prostate carcinoma using pimonidazole: Implications for radioresistance. International Journal of Radiation Oncology Biology Physics , 65 (1) pp. 91-99.

Caroline, R; (2006) I was saved from death by cells harvested from my bones. The Daily Mail

Carr, AJF; Tamai, TK; Young, LC; Ferrer, V; Dekens, MP; Whitmore, D; (2006) Light reaches the very heart of the zebrafish clock. CHRONOBIOLOGY INTERNATIONAL , 23 (1-2) 91 - 100. 10.1080/07420520500464395.

Carrasco, DR; Fenton, T; Sukhdeo, K; Protopopova, M; Enos, M; You, MJ; Di Vizio, D; ... Depinho, RA; + view all (2006) The PTEN and INK4A/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humans. Cancer Cell , 9 (5) pp. 379-390. 10.1016/j.ccr.2006.03.028.

Casado, E; Tabernero, J; Melichar, B; Bridgewater, J; Bennouna, J; Delord, J; Sopala, M; ... Johri, A; + view all (2006) Patupilone in chemotherapy-pretreated patients with advanced colorectal cancer (CRC) receiving nutritional support and intensive diarrhea management: A phase I multicenter trial. J Clin Oncol , 24 (18_suppl) 3593-.

Caswell, R; Warner, TT; Mehta, A; Ginsberg, L; (2006) POEMS syndrome. Practical Neurology , 6 pp. 14-26.

Cave, J; Davis, B; Lee, SM; Jones, A; (2006) A randomised controlled trial comparing symptom-based and tumour-based teaching for undergraduates medical students. In: (Proceedings) 2006 NCRI Cancer Conference, Birmingham.. (pp. 192-). Annals of Oncology

Cerdan, C; Bendall, SC; Wang, L; Stewart, M; Werbowetski, T; Bhatia, M; (2006) Complement targeting of nonhuman sialic acid does not mediate cell death of human embryonic stem cells. NATURE MEDICINE , 12 (10) pp. 1113-1114. 10.1038/nm1006-1113.

Cerone, MA; Londoño-Vallejo, JA; Autexier, C; (2006) Mutated telomeres sensitize tumor cells to anticancer drugs independently of telomere shortening and mechanisms of telomere maintenance. Oncogene , 25 (56) pp. 7411-7420. 10.1038/sj.onc.1209727.

Cerone, MA; Londoño-Vallejo, JA; Autexier, C; (2006) Telomerase inhibition enhances the response to anticancer drug treatment in human breast cancer cells. Mol Cancer Ther , 5 (7) pp. 1669-1675. 10.1158/1535-7163.MCT-06-0033.

Chakraverty, R; Cote, D; Buchli, J; Cotter, P; Hsu, R; Zhao, GL; Sachs, T; ... Sykes, M; + view all (2006) An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues. J EXP MED , 203 (8) 2021 - 2031. 10.1084/jem.20060376. Green open access
file

Chakraverty, R; Dimopoulou, M; Glanville, J; Thomson, K; Peggs, K; Milligan, D; Cook, G; ... Mackinnon, S; + view all (2006) De-Escalation of the Alemtuzumab Dose Prior to Nonmyeloablative HLA-Identical Sibling Transplantation: Crucial Role of Timing. In: (Proceedings) American Society of Haematology.

Chakraverty, R; Dimopoulou, M; Glanville, J; Thomson, K; Peggs, K; Milligan, D; Cook, G; ... Mackinnon, S; + view all (2006) De-escalation of the alemtuzumab dose prior to nonmyeloablative HLA-identical sibling transplantation: Crucial role of timing. In: BLOOD. (pp. 821A - 822A). AMER SOC HEMATOLOGY

Chang, JC; Makris, A; Hilsenbeck, SJ; Hackett, JR; Jeong, J; Liu, M; Baker, J; ... Shak, S; + view all (2006) Gene expression profiles in formalin-fixed, paraffin-embedded (FFPE) core biopsies predict docetaxel chemosensitivity. In: (pp. 12S-12S).

Channel, 5N; (2006) Cancer drug battle. UNSPECIFIED

Chantrain, CF; Bruwier, A; Brichard, B; Largent, V; Chapgier, A; Feinberg, J; Casanova, J-L; ... Vermylen, C; + view all (2006) Successful hematopoietic stem cell transplantation in a child with active disseminated Mycobacterium fortuitum infection and interferon-gamma receptor 1 deficiency. Bone Marrow Transplant , 38 (1) pp. 75-76. 10.1038/sj.bmt.1705399.

Chantry, AD; Snowden, JA; Craddock, C; Peggs, K; Roddie, C; Craig, JIO; Orchard, K; ... Marks, DI; + view all (2006) Long-term outcomes of myeloablation and autologous transplantation of relapsed acute myeloid leukemia in second remission: A British Society of Blood and Marrow Transplantation registry study. BIOL BLOOD MARROW TR , 12 (12) 1310 - 1317. 10.1016/j.bbmt.2006.07.015.

Chapgier, A; Boisson-Dupuis, S; Jouanguy, E; Vogt, G; Feinberg, J; Prochnicka-Chalufour, A; Casrouge, A; ... Casanova, JL; + view all (2006) Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease. PLoS Genetics , 2 (8) e131 -. 10.1371/journal.pgen.0020131. Green open access
file

Chapgier, A; Wynn, RF; Jouanguy, E; Filipe-Santos, O; Zhang, S; Feinberg, J; Hawkins, K; ... Arkwright, PD; + view all (2006) Human complete Stat-1 deficiency is associated with defective type I and II IFN responses in vitro but immunity to some low virulence viruses in vivo. J Immunol , 176 (8) pp. 5078-5083.

Chapman, CE; Williamson, LM; Cohen, H; Stainsby, D; Jones, H; (2006) The impact of using male donor plasma on haemovigilance reports of transfusion related acute lung injury (TRALI) in the UK. Presented at: UNSPECIFIED.

Chiang, CLL; Ledermann, JA; Rad, AN; Katz, DR; Chain, BM; (2006) Hypochlorous acid enhances immunogenicity and uptake of allogeneic ovarian tumor cells by dendritic cells to cross-prime tumor-specific T cells. CANCER IMMUNOL IMMUN , 55 (11) 1384 - 1395. 10.1007/s00262-006-0127-9.

Chicken, DW; Clarke, B; Mosse, S; Falzon, M; Kocjan, G; Bown, S; Keshtgar, MRS; (2006) Rapid Intraoperative Diagnosis of Sentinel Node Metastases in Breast Cancer using Elastic Scattering Spectroscopy Scanning. In: (pp. p. 1026).

Chicken, DW; Clarke, BR; Johnson, KS; Falzon, M; Novelli, M; Bigio, IJ; Bown, SG; (2006) Elastic scattering spectroscopy a rapid optical technique for detection of sentinel node metastases in breast cancer. In: (pp. 104-).

Chicken, DW; Kocjan, G; Falzon, M; Lee, AC; Douek, M; Sainsbury, R; Keshtgar, MRS; (2006) Intraoperative touch imprint cytology for the diagnosis of sentinel lymph node metastases in breast cancer. BRIT J SURG , 93 (5) 572 - 576. 10.1002/bjs.5289.

Chin, Y; Ravichandran, D; Makris, A; (2006) Exemestane after non-steroidal aromatase inhibitors for post-menopaual women with advanced breast cancer. In: (pp. 167-).

Chin, YS; Bullard, J; Bryant, L; Bownes, P; Ostler, P; Hoskin, PJ; (2006) High dose rate iridium-192 brachytherapy as a component of radical radiotherapy for the treatment of localised prostate cancer. CLINICAL ONCOLOGY , 18 (7) pp. 474-479.

Cholongitas, E; Quaglia, A; Dhillon, AP; Patch, D; Burroughs, AK; (2006) Length versus width in liver biopsies. J HEPATOL , 44 (4) 822 - 823. 10.1016/j.jhep.2005.12.023.

Cholongitas, E; Quaglia, A; Samonakis, D; Papatheodoridis, GV; Patch, D; Dhillon, AP; Burroughs, AK; (2006) Patients with recurrent HCV infection and renal dysfunction after liver transplantation have slower fibrosis progression. In: LIVER TRANSPLANTATION. (pp. C60 - C60). JOHN WILEY & SONS INC

Cholongitas, E; Quaglia, A; Samonakis, D; Papatheodoridis, GV; Senzolo, M; Triantos, C; Patch, D; ... Burroughs, AK; + view all (2006) Patients with recurrent HCV infection and renal dysfunction after liver transplantation have slower fibrosis progression. In: JOURNAL OF HEPATOLOGY. (pp. S58 - S59). ELSEVIER SCIENCE BV

Cholongitas, E; Quaglia, A; Samonakis, D; Senzolo, M; Triantos, C; Patch, D; Leandro, G; ... Burroughs, AK; + view all (2006) Transjugular liver biopsy: how good is it for accurate histological interpretation? GUT , 55 (12) 1789 - 1794. 10.1136/gut.2005.090415.

Cholongitas, E; Samonakis, D; Manousou, P; Shusang, V; Dhillon, AP; Quaglia, A; Sharma, D; ... Burroughs, AK; + view all (2006) Randomised trial of tacrolimus monotherapy vs. tacrolimus/azathioprine/prednisolone after liver transplantation for HCV cirrhosis. LIVER TRANSPLANTATION , 12 (5) C61 - C61.

Cholongitas, E; Samonakis, D; Patch, D; Senzolo, M; Burroughs, AK; Quaglia, A; Dhillon, A; (2006) Induction of autoimmune hepatitis by pegylated interferon in a liver transplant patient with recurrent hepatitis C virus. Transplantation , 81 (3) pp. 488-490. 10.1097/01.tp.0000196716.07188.c4.

Cholongitas, E; Senzolo, M; Standish, R; Marelli, L; Quaglia, A; Patch, D; Dhillon, AP; (2006) A systematic review of the quality of liver biopsy specimens. AM J CLIN PATHOL , 125 (5) 710 - 721. 10.1309/W3XCNT4HKFBN2G0B.

Cholongitas, E; Senzolo, M; Standish, R; Marelli, L; Quaglia, A; Patch, D; Dhillon, AP; (2006) A systematic review of the quality of liver biopsy specimens. Am J Clin Pathol , 125 (5) pp. 710-721. 10.1309/W3XC-NT4H-KFBN-2G0B.

Chong, G; Bhatnagar, A; Cunningham, D; Cosgriff, TM; Harper, PG; Steward, W; Bridgewater, J; ... Carmichael, J; + view all (2006) Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 anti-idiotype monoclonal antibody or placebo in patients with advanced colorectal cancer. Ann Oncol , 17 (3) pp. 437-442. 10.1093/annonc/mdj090.

Chow, E; Hoskin, P; van der Linden, Y; Bottomley, A; Velikova, G; (2006) Quality of life and symptom end points in palliative bone metastases trials. ELSEVIER SCIENCE LONDON, 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND

Chow, E; Hoskin, PJ; Wu, J; Roos, D; van der Linden, Y; Hartsell, W; Vieth, R; ... Pater, J; + view all (2006) A phase III international randomised trial comparing single with multiple fractions for re-irradiation of painful bone metastases: National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) SC 20. ELSEVIER SCIENCE LONDON, 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND

Clamp, AR; Maenpaa, J; Cruickshank, D; Ledermann, J; Wilkinson, PM; Welch, R; Chan, S; ... Jayson, GC; + view all (2006) SCOTROC 2B: feasibility of carboplatin followed by docetaxel or docetaxel-irinotecan as first-line therapy for ovarian cancer. BRITISH JOURNAL OF CANCER , 94 (1) pp. 55-61. 10.1038/sj.bjc.6602910.

Clark, DA; Leong, HN; Nacheva, EP; Tsao, EHF; Griffiths, PD; Ward, KN; (2006) Chromosomal integration of human herpesvirus 6. In: JOURNAL OF CLINICAL VIROLOGY. (pp. S104 - S104). ELSEVIER SCIENCE BV

Clark, DA; Nacheva, EP; Leong, HN; Brazma, D; Li, YT; Tsao, EHF; Buyck, HCE; ... Griffiths, PD; + view all (2006) Transmission of integrated human herpesvirus 6 through stem cell transplantation: Implications for laboratory diagnosis. In: JOURNAL OF INFECTIOUS DISEASES. (pp. 912 - 916). UNIV CHICAGO PRESS

Clark, DA; Tsao, EHF; Leong, HN; Ward, KN; Nacheva, EP; Griffiths, PD; (2006) Human herpesvirus 6 latency characterized by high viral load: Chromosomal integration in many, but not all, cells - Reply to Boutolleau et al. and Luppi et al. J INFECT DIS , 194 (7) 1021 - 1023.

Cleator, S; Makris, A; Powles, T; (2006) Response to letter "Analysis of breast cancer survival by clinical response to neoadjuvant chemoendocrine therapy" by Bogaerts et al. (Ann Oncol 2006; 17 : 352-353). UNSPECIFIED

Clements, MO; Godfrey, A; Crossley, J; Wilson, SJ; Takeuchi, Y; Boshoff, C; (2006) Lentiviral manipulation of gene expression in human adult and embryonic stem cells. TISSUE ENG , 12 (7) 1741 - 1751.

Coakley, M; Reddy, K; Mackie, I; Mallett, S; (2006) Transfusion triggers in orthotopic liver transplantation: A comparison of the thromboelastometry analyzer, the thromboelastogram, and conventional coagulation tests. J CARDIOTHOR VASC AN , 20 (4) 548 - 553. 10.1053/j.jvca.2006.01.016.

Cohen, H; Austin, SK; Lawrie, AS; Starke, RD; Scully, M; Machin, S; Cohen, H; (2006) ADAMTS13 antibodies in patients with antiphospholipid antibodies. In:

Collin, MP; Hart, DNJ; Jackson, GH; Cook, G; Cavet, J; Mackinnon, S; Middleton, PG; (2006) The fate of human Langerhans cells in hematopoietic stem cell transplantation. J EXP MED , 203 (1) 27 - 33. 10.1084/jem.20051787.

Conde, L; Vaquerizas, JM; Dopazo, H; Arbiza, L; Reumers, J; Rousseau, F; Schymkowitz, J; (2006) PupaSuite: finding functional single nucleotide polymorphisms for large-scale genotyping purposes. Nucleic Acids Res , 34 (Web Serv) W621-W625. 10.1093/nar/gkl071.

Cook, G; Clark, RE; Crawley, C; Mackinnon, S; Russell, N; Thomson, K; Pearce, RM; ... Marks, DI; + view all (2006) The outcome of sibling and unrelated donor allogeneic stem cell transplantation in adult patients with acute myeloid leukemia in first remission who were initially refractory to first induction chemotherapy. BIOL BLOOD MARROW TR , 12 (3) 293 - 300. 10.1016/j.bbmt.2005.10.019.

Cooper, CS; Nicholson, AG; Foster, C; Dodson, A; Edwards, S; Fletcher, A; Roe, T; ... Cheng, SJ; + view all (2006) Nuclear overexpression of the E2F3 transcription factor in human lung cancer. LUNG CANCER , 54 (2) 155 - 162. 10.1016/j.lungcan.2006.07.005.

Corsini, E; Viviani, B; Birindelli, S; Gilardi, F; Torri, A; Codeca, I; Lucchi, L; ... Colosio, C; + view all (2006) Molecular mechanisms underlying mancozeb-induced inhibition of TNF-alpha production. TOXICOL APPL PHARM , 212 (2) 89 - 98. 10.1016/j.taap.2005.07.002.

Crespo, M; Villamor, N; Gin, E; Muntaola, A; Colomer, D; Marafioti, T; Jones, M; ... Bosch, F; + view all (2006) ZAP-70 expression in normal pro/pre B cells, mature B cells, and in B-cell acute lymphoblastic leukemia. Clin Cancer Res , 12 (3 Pt 1) pp. 726-734. 10.1158/1078-0432.CCR-05-1531.

Cunningham, F; Rios, D; Griffiths, M; Smith, J; Ning, Z; Cox, T; Flicek, P; ... Adams, DJ; + view all (2006) TranscriptSNPView: a genome-wide catalog of mouse coding variation. Nat Genet , 38 (8) 853-. 10.1038/ng0806-853a.

Cutillas, PR; Khwaja, A; Graupera, M; Pearce, W; Gharbi, S; Waterfield, M; Vanhaesebroeck, B; (2006) Ultrasensitive and absolute quantification of the phosphoinositide 3-kinase/Akt signal transduction pathway by mass spectrometry. P NATL ACAD SCI USA , 103 (24) 8959 - 8964. 10.1073/pnas.0602101103. Gold open access

D

Dachs, GU; Steele, AJ; Coralli, C; Kanthou, C; Brooks, AC; Gunningham, SP; Currie, MJ; ... Tozer, GM; + view all (2006) Anti-vascular agent Combretastatin A-4-P modulates Hypoxia Inducible Factor-1 and gene expression. BMC Cancer , 6 , Article 280. 10.1186/1471-2407-6-280. Green open access
file

Dahl, KN; Scaffidi, P; Islam, MF; Yodh, AG; Wilson, KL; Misteli, T; (2006) Distinct structural and mechanical properties of the nuclear lamina in Hutchinson-Gilford progeria syndrome. Proceedings of the National Academy of Sciences , 103 (27) pp. 10271-10276. 10.1073/pnas.0601058103.

Damelin, M; Ooi, SKT; Bestor, TH; (2006) Combing over heritable gene silencing. NAT STRUCT MOL BIOL , 13 (2) 100 - 101. 10.1038/nsmb0206-100.

Daniels, S; Statham, P; Globe, D; Seddon, B; Whelan, J; (2006) Piloting a novel method of administration – Moving inpatient treatments to ambulatory care. In:

Danos, O; Svinartchouk, F; (2006) Dialysis-assisted two-dimensional gel electrophoresis. Electrophoresis , 27 (17) pp. 3475-3479. 10.1002/elps.200500036.

Das-Gupta, EP; Byrne, JL; Gilyead, M; Shaw, BE; Russell, NH; (2006) Long-term results of pre-transplant in vivo alemtuzumab for unrelated donor transplantation in acute myeloid leukaemia. In: BONE MARROW TRANSPLANTATION. (pp. S116 - S116). NATURE PUBLISHING GROUP

De Santis, D; Witt, C; Gomez-Lozano, N; Vilches, C; Garcia, CA; Marsh, SGE; Williams, F; ... Christiansen, F; + view all (2006) A multi-laboratory evaluation of reference cells for KIR typing. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 1233-1236). IHWG Press: Seattle.

De Sousa, PA; Fletcher, JM; Ferrier, PM; Gardner, JO; Harkness, L; Dhanjal, S; Harper, J; ... Wilmut, I; + view all (2006) Isolation of new therapeutically suitable human embryo stem cell lines without direct exposure to animal cell products. In: CELL TRANSPLANTATION. (pp. 541 - 541). COGNIZANT COMMUNICATION CORP

Deakin, JE; Papenfuss, AT; Belov, K; Cross, JGR; Coggill, P; Palmer, S; Sims, S; ... Graves, JAM; + view all (2006) Evolution and comparative analysis of the MHC Class III inflammatory region. BMC GENOMICS , 7 , Article 281. 10.1186/1471-2164-7-281. Gold open access

Deegan, PB; Baehner, AF; Barba Romero, M-Á; Hughes, DA; Kampmann, C; Beck, M; (2006) Natural history of Fabry disease in females in the Fabry Outcome Survey. Journal of medical Genetics , 43 pp. 347-352.

Delgado, J; Cooper, N; Thomson, K; Duarte, R; Jarmulowicz, M; Cassoni, A; Kortaridis, P; ... Mackinnon, S; + view all (2006) The importance of age, fludarabine, and total body irradiation in the incidence and severity of chronic renal failure after allogeneic hematopoietic cell transplantation. BIOL BLOOD MARROW TR , 12 (1) 75 - 83. 10.1016/j.bbmt.2005.08.036.

Delgado, J; Thomson, K; Russell, N; Ewing, J; Stewart, W; Cook, G; Devereux, S; ... Milligan, DW; + view all (2006) Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study. BLOOD , 107 (4) 1724 - 1730. 10.1182/blood-2005-08-3372.

Descamps, MJL; Barrett, L; Groves, M; Yung, L; Birch, R; Murray, NMF; Linch, DC; ... Reilly, MM; + view all (2006) Primary sciatic nerve lymphoma: a case report and review of the literature. J NEUROL NEUROSUR PS , 77 (9) 1087 - 1089. 10.1136/jnnp.2006.087577.

Desigan, S; Hall-Craggs, MA; Ho, CP; Eliahoo, J; Porter, JB; (2006) Degenerative disc disease as a cause of back pain in the thalassaemic population: a case-control study using MRI and plain radiographs. SKELETAL RADIOL , 35 (2) 95 - 102. 10.1007/s00256-005-0020-1.

Dhanjal, S; Kakourou, G; Saleh, N; Mamas, T; Doshi, A; Gotts, S; Nuttall, S; ... SenGupta, S; + view all (2006) Preimplantation genetic diagnosis for retinoblastoma predisposition. In: JOURNAL OF MEDICAL GENETICS. (pp. S58 - S58). B M J PUBLISHING GROUP

Dhar, A; Johnson, KS; Novelli, MR; Bown, SG; Bigio, IJ; Lovat, LB; Bloom, SL; (2006) Elastic scattering spectroscopy for the diagnosis of colonic lesions: initial results of a novel optical biopsy technique. GASTROINTEST ENDOSC , 63 (2) 257 - 261. 10.1016/j.gie.2005.07.026.

Direkze, S.G.; (2006) Characterisation of transcriptional mediator subunit, MED17 and its regulation by cyclins. Doctoral thesis, University of London. Green open access
file

Dische, S; Rojas, A; Saunders, M; (2006) What can be learnt from a final follow up study of the chart pilot study? In: (pp. S131-S131).

Donovan, E; Coles, C; Westbury, C; Yarnold, J; (2006) Breast. In: External Beam Therapy. Oxford University Press

Duarte, RF; Pamphilon, D; Cornish, J; Shaw, BE; Samson, D; Craddock, C; Marks, D; ... Goldman, JM; + view all (2006) Topical issues in unrelated donor haematopoietic stem cell transplants: a report from a workshop convened by the Anthony Nolan Trust in London - 2005. BONE MARROW TRANSPL , 37 (10) 901 - 908. 10.1038/sj.bmt.1705365.

Dzwonek, A; Clapson, M; Withey, S; Bates, A; Novelli, V; (2006) Severe gynecomastia in an African boy with perinatally acquired human immunodeficiency virus infection receiving highly active antiretroviral therapy. The Pediatric Infectious Disease Journal , 25 (2) pp. 183-184.

de Bakker, PIW; McVean, G; Sabeti, PC; Miretti, MM; Green, T; Marchini, J; Ke, XY; ... Rioux, JD; + view all (2006) A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. NAT GENET , 38 (10) 1166 - 1172. 10.1038/ng1885.

de Bruin, EC; van de Velde, CJH; van de Pas, S; Nagtegaal, ID; van Krieken, JHJM; Gosens, MJEM; Peltenburg, LTC; ... Marijnen, CAM; + view all (2006) Prognostic value of apoptosis in rectal cancer patients of the dutch total mesorectal excision trial: radiotherapy is redundant in intrinsically high-apoptotic tumors. Clin Cancer Res , 12 (21) pp. 6432-6436. 10.1158/1078-0432.CCR-06-0231.

de Laat, B; Derksen, RHWM; Mackie, IJ; Roest, M; Schoormans, S; Woodhams, BJ; de Groot, PG; (2006) Annexin A5 polymorphism (-1C -> T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome. ANN RHEUM DIS , 65 (11) 1468 - 1472. 10.1136/ard.2005.045237.

E

Eckhardt, F; Lewin, J; Cortese, R; Rakyan, VK; Attwood, J; Burger, M; Burton, J; ... Beck, S; + view all (2006) DNA methylation profiling of human chromosomes 6, 20 and 22. NAT GENET , 38 (12) 1378 - 1385. 10.1038/ng1909.

El, EE; Dearling, J; Huhalov, A; Robson, P; Neri, D; van, DGA; Zardi, L; ... Pedley, RB; + view all (2006) Targeting the tumour vasculature: therapeutic efficacy of a 131I-labeled antibody against the ED-B domain of fibronectin. In: (Proceedings) NCRI Cancer Conference proceedings. (pp. 63-).

El, EE; Dearling, J; Huhalov, A; Robson, P; Neri, D; van, DGA; Zardi, L; ... Pedley, RB; + view all (2006) Targeting tumour vasculature in human colorectal xenografts using an antibody against the extra-domain B of fibronectin. BACR/BMS Tumour vasculature: New targets and Therapies. In: (pp. 18-).

Ellis, SA; Bontrop, RE; Antczak, D; Ballingall, K; Davies, CJ; Kaufman, J; Kennedy, LJ; ... Marsh, SGE; + view all (2006) ISAG/IUIS-VIC Comparative MHC Nomenclature Committee Report, 2005. Immunogenetics , 57 pp. 953-958.

Enver, T; Tsuzuki, S; Brown, J; Hong, D; Gupta, R; Ford, A; Egguchi, MI; ... Greaves, M; + view all (2006) Developmental impact of leukemic fusion genes on stem cell fate. Ann N Y Acad Sci. , 1044 pp. 16-23. 10.1196/annals.1349.003.

Etessami, N; Lam, L; Berisha, F; Flanagan, AM; Diss, TC; (2006) Improved detection of FUS-CHOP fusion transcript in myxoid liposarcoma using real-time RT-PCR. In: (Proceedings) 190th Meeting of the Pathological-Society-of-Great-Britain-and-Ireland. (pp. p. 25). WILEY-BLACKWELL

Everington, TF; Henderson, S; Gale, R; Linch, DC; Khwaja, A; (2006) Primary erythroblasts from patients with polycythaemia vera (PV) have a distinct gene expression signature from both idiopathic erythrocytosis (IE) and normal controls which shows limited changes in Jak-STAT target genes. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 79 - 79). BLACKWELL PUBLISHING

Everington, TF; Linch, DC; Khwaja, A; (2006) Reversal of apoptosis resistance and erythropoietin independent growth of primary erythroid progenitors from patients with polycythaemia vera (PV) by inhibitors of the Jak2 tyrosine kinase. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 33 - 34). BLACKWELL PUBLISHING

F

Field, D; Wilson, G; van der Gast, C; (2006) How do we compare hundreds of bacterial genomes? Curr Opin Microbiol , 9 (5) pp. 499-504.

Filipe-Santos, O; Bustamante, J; Chapgier, A; Vogt, G; de Beaucoudrey, L; Feinberg, J; Jouanguy, E; ... Casanova, J-L; + view all (2006) Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol , 18 (6) pp. 347-361. 10.1016/j.smim.2006.07.010.

Filipe-Santos, O; Bustamante, J; Haverkamp, MH; Vinolo, E; Ku, C-L; Puel, A; Frucht, DM; ... Casanova, J-L; + view all (2006) X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J Exp Med , 203 (7) pp. 1745-1759. 10.1084/jem.20060085.

Finnegan, DPJ; Kettle, P; Drake, M; Matthews, C; Alexander, HD; Popat, R; Cavanagh, JD; ... Morris, TCM; + view all (2006) Bortezomib is effective in primary plasma cell leukemia. LEUKEMIA & LYMPHOMA , 47 (8) pp. 1670-1673. 10.1080/10428190500520954.

Fitzmaurice, DA; Gardiner, C; Kitchen, S; Mackie, I; Murray, ET; Machin, SJ; (2006) Erratum: An evidence based review and guidelines for patient self-testing and management of oral anticoagulation (British Journal of Haematology (2005) 131 (156-165)). British Journal of Haematology , 132 (1) 118-. 10.1111/j.1365-2141.2005.05830.x.

Flanagan, J; Popendikyte, V; Pozdniakovaite, N; Sobolev, M; Assadzadeh, A; Schumacher, A; Zangeneh, M; ... Petronis, A; + view all (2006) Intra- and Inter- Individual Epigenetic Variation in Human Germ Cells. The American Journal of Human Genetics , 79 (1) pp. 67-84.

Fletcher, JM; Ferrier, PM; Gardner, JO; Harkness, L; Dhanjal, S; Serhal, P; Harper, J; ... De Sousa, PA; + view all (2006) Variations in humanized and defined culture conditions supporting derivation of new human embryonic stem cell lines. CLONING STEM CELLS , 8 (4) 319 - 334.

Flood, C; Cosgrove, T; Howell, I; Revell, P; (2006) Effects of electrolytes on adsorbed polymer layers: poly(ethylene oxide)-silica system. Langmuir , 23 (5) pp. 2408-2413. 10.1021/la062034b.

Flores, L; Staples, A; Mackay, H; Howard, C; Uthe, P; Sexton, J; Buchmueller, K; ... Lee, M; + view all (2006) Synthesis and evaluation of LVF-I-141: An intercalator-polyamide hairpin designed to target the inverted CCAAT box 2 in the topoisomerase II alpha promoter. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY , 231 ? - ?.

Flores, LV; Staples, AM; Mackay, H; Howard, CM; Uthe, PB; Sexton, JS; Buchmueller, KL; ... Lee, M; + view all (2006) Synthesis and evaluation of an intercalator-polyamide hairpin designed to target the inverted CCAAT box 2 in the topoisomerase II alpha promoter. CHEMBIOCHEM , 7 (11) 1722 - 1729. 10.1002/cbic.200600155.

Florijn, RJ; Loves, W; Wenniger-Prick, LJJMMD; Mannens, MMAM; Tijmes, N; Brooks, SP; Hardcastle, AJ; (2006) New mutations in the NHS gene in Nance-Horan Syndrome families from the Netherlands. EUR J HUM GENET , 14 (9) 986 - 990. 10.1038/sj.ejhg.5201671.

Follows, GA; Dhami, P; Gottgens, B; Bruce, AW; Campbell, PJ; Dillon, SC; Smith, AM; ... Green, AR; + view all (2006) Identifying gene regulatory elements by genomic microarray mapping of DNaseI hypersensitive sites. GENOME RES , 16 (10) 1310 - 1319. 10.1101/gr.5373606.

Forbes, S; Clements, J; Dawson, E; Bamford, S; Webb, T; Dogan, A; Flanagan, AM; ... Stratton, MR; + view all (2006) COSMIC 2005. British Journal of Cancer , 94 (2) pp. 310-322.

Ford, HER; Yap, YS; Miles, DW; Makris, A; Hall, M; Miller, L; Harries, M; ... Johnston, SRD; + view all (2006) A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer. Cancer Chemotherapy and Pharmacology , 58 (6) pp. 809-815.

Foroni, L; Mitchell, W; Rai, L; Gerrard, G; Patel, B; Goldstone, A; (2006) Molecular monitoring of minimal residual disease in adult ALL, the UKALL12 trial experience. In: (Proceedings) 46th Annual Scientific Meetign of the British-Society-for-Haematology. (pp. p. 52). BLACKWELL PUBLISHING

Foukas, LC; Claret, M; Pearce, W; Okkenhaug, K; Meek, S; Peskett, E; Sancho, S; ... Vanhaesebroeck, B; + view all (2006) Critical role for the p110 alpha phosphoinositide-3-OH kinase in growth and metabolic regulation. NATURE , 441 (7091) pp. 366-370. 10.1038/nature04694.

Fox, J; Alabassi, A; Patkar, V; Rose, T; Black, E; (2006) An ontological approach to modelling tasks and goals. COMPUT BIOL MED , 36 (7-8) 837 - 856. 10.1016/j.compbiomed.2005.04.011.

Fox, J; Patkar, V; Thomson, R; (2006) Decision support for health care: the PROforma evidence base. Inform Prim Care , 14 (1) pp. 49-54.

Friedmann, BJ; Caplin, M; Savic, B; Shah, T; Lord, CJ; Ashworth, A; Hartley, JA; (2006) Interaction of the epidermal growth factor receptor and the DNA-dependent protein kinase pathway following gefitinib treatment. MOL CANCER THER , 5 (2) 209 - 218. 10.1158/1535-7163.MCT-05-0239.

Fry, AM; Yamano, H; (2006) APC/C-mediated degradation in early mitosis: how to avoid spindle assembly checkpoint inhibition. Cell Cycle , 5 (14) pp. 1487-1491.

Fukuuchi, A; Nagamura, Y; Yaguchi, H; Ohkura, N; Obara, T; Tsukada, T; (2006) A whole MEN1 gene deletion flanked by Alu repeats in a family with multiple endocrine neoplasia type 1. Jpn J Clin Oncol , 36 (11) pp. 739-744. 10.1093/jjco/hyl089.

Fung, EB; Harmatz, PR; Lee, PDK; Milet, M; Bellevue, R; Jeng, MR; Kalinyak, KA; ... Multi-Centre Study of Iron Overload Research Group, ; + view all (2006) Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease. Br J Haematol , 135 (4) pp. 574-582. 10.1111/j.1365-2141.2006.06332.x.

G

Gale, RE; Allen, AJR; Nash, MJ; Linch, DC; (2006) Lack of correlation of clonality status with the level of Val617Phe JAK2 mutant in essential thrombocythaemia (ET) indicates that the JAK2 when present, is not the primary pathogenic event. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 12 - 12). BLACKWELL PUBLISHING

Gale, RE; Hills, R; Wheatley, K; Burnett, AK; Linch, DC; (2006) Response: Allogeneic stem cell transplantation and FLT3/ITD status in AML. BLOOD , 108 (1) 400 - 401.

Garcia, CA; Robinson, J; Guethlein, LA; Vilches, C; Parham, P; Madrigal, JA; Marsh, SGE; (2006) Human Killer-cell Immunoglobulin-like Receptor (KIR) polymorphism. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 1208-1232). IHWG Press: Seattle.

Garcia, CA; Robinson, J; Shilling, HG; Guethlein, LA; Parham, P; Madrigal, JA; Marsh, SGE; (2006) KIR gene characterisation of HLA homozygous cell lines. In Immunobiology of the Human MHC. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 1203-1207). IHWG Press: Seattle.

Garcia, J-F; Roncador, G; Garca, J-F; Snz, A-I; Maestre, L; Lucas, E; Montes-Moreno, S; ... Piris, MA; + view all (2006) PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma. Haematologica , 91 (4) pp. 467-474.

Garcia-Ortiz, JE; Sandoval-Ramirez, L; Rangel-Villalobos, H; Maldonado-Torres, H; Cox, S; Garcia-Sepulveda, CA; Figuera, LE; ... Arguello, JR; + view all (2006) High-resolution molecular characterization of the HLA class I and class II in the Tarahumara Amerindian population. TISSUE ANTIGENS , 68 (2) pp. 135-146. 10.1111/j.1399-0039.2006.00636.x.

Garden, OJ; Rees, M; Poston, GJ; Mirza, D; Saunders, M; Ledermann, J; Primrose, JN; (2006) Guidelines for resection of colorectal cancer liver metastases. GUT , 55 (ARTN iii) pp. 1-8. 10.1136/gut.2006.098053.

Gardiner, C; Cohen, H; Austin, SK; Machin, SJ; Mackie, IJ; (2006) Pregnancy loss, tissue factor pathway inhibitor deficiency and resistance to activated protein C. J THROMB HAEMOST , 4 (12) 2724 - 2726.

Gardiner, C; Cohen, H; Austin, SK; Machin, SJ; Mackie, IJ; (2006) Pregnancy loss, tissue factor pathway inhibitor deficiency and resistance to activated protein C. Journal of thrombosis and haemostasis : JTH , 4 pp. 2724-2726.

Gardiner, C; Cohen, H; Jenkins, A; Machin, SJ; Mackie, IJ; (2006) Detection of acquired resistance to activated protein C associated with antiphospholipid antibodies using a novel clotting assay. BLOOD COAGUL FIBRIN , 17 (6) 477 - 483.

Gardiner, C; Kitchen, S; Dauer, RJ; Kottke-Marchant, K; Adcock, DM; (2006) Recommendations for evaluation of coagulation analyzers. Lab Hematol , 12 (1) pp. 32-38. 10.1532/LH96.05031.

Gardiner, C; Williams, K; Longair, I; Mackie, IJ; Machin, SJ; Cohen, H; (2006) A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing. BRIT J HAEMATOL , 132 (5) 598 - 603. 10.1111/j.1365-2141.2005.05899.x.

Gardiner, C; Williams, K; Mackie, IJ; Machin, SJ; Cohen, H; (2006) Can oral anticoagulation be managed using telemedicine and patient self-testing? A pilot study. CLIN LAB HAEMATOL , 28 (2) 122 - 125.

Gerrard, G; Mitchell, W; Patel, B; Goldstone, A; Fielding, A; Foroni, L; (2006) Minimal residual disease monitoring of BCR-ABL(+) adult acute lymphoblastic leukaemia using quantitative real-time PCR: preliminary results from the UKALLXII trial. In: (Proceedings) 46th Annual Scientific Meetign of the British-Society-for-Haematology. (pp. pp. 53-54). BLACKWELL PUBLISHING

Gilardi, F; Viviani, B; Torri, A; Bartesaghi, S; Maschi, O; Caruso, D; Crestani, M; ... De Fabiani, E; + view all (2006) Differential expression and regulation of genes involved in cholesterol metabolism in brain cells. In: CHEMISTRY AND PHYSICS OF LIPIDS. (pp. 93 - 93). ELSEVIER IRELAND LTD

Glanville, J; Eleftheriou, P; Porter, J; (2006) MRI evidence of cardiac accumulation in myelodysplasia and unusual anaemias. In: BLOOD. (pp. 446A - 446A). AMER SOC HEMATOLOGY

Glasow, A; Barrett, A; Boix i Chornet, M; Gupta, R; Zhou, D-C; Gallagher, R; von Lindern, M; ... Zelent, A; + view all (2006) DNA methylation independent silencing of the RAR alpha gene expression in acute myeloid leukemia. In: (Proceedings) 48th Annual Meeting of the American-Society-of-Hematology. (pp. 630A-631A). AMER SOC HEMATOLOGY

Glynne-Jones, R; Grainger, J; Harrison, M; Ostler, P; Makris, A; (2006) Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious? BRITISH JOURNAL OF CANCER , 94 (3) pp. 363-371.

Gomes, CMF; Welling, MM; Que, I; Henriquez, NV; van der Pluijm, G; Romeo, S; Abrunhosa, AJ; ... Cleton-Jansen, AM; + view all (2006) Molecular imaging of multidrug resistance in an orthotopic model of osteosarcoma. EUR J NUCL MED MOL I , 33 S209 - S209.

Gomez, K; McVey, JH; (2006) Tissue factor initiated blood coagulation. Frontiers in Bioscience , 11 pp. 1349-1359.

Gooding, CR; Bartlett, W; Bentley, G; Skinner, JA; Carrington, R; Flanagan, A; (2006) A prospective, ranomised study comparing two techniques of autologous chondrocyte implantation for osteochondral defects in the knee: Periosteum covered versus type I/III collagen covered. Knee , 13 (3) pp. 203-210.

Graham, J; Wagner, K; Plummer, R; Wiedenmann, B; Cassidy, J; Kowal, K; McCoy, C; (2006) Phase I dose-escalation study of novel oral multi-target tumor growth inhibitor (MTGI) ZK 304709 administered daily for 7 days of a 21-day cycle to patients with advanced solid tumors. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 97S - 97S). AMER SOC CLINICAL ONCOLOGY

Graham, J; Wagner, K; Plummer, R; Wiedenmann, B; Cassidy, J; Kowal, K; McCoy, C; (2006) Phase I dose-escalation study of novel oral multi-target tumor growth inhibitor (MTGI) ZK 304709 administered daily for 7 days of a 21-day cycle to patients with advanced solid tumors. J Clin Oncol , 24 (18_suppl) 2073-.

Grandage, VL; Everington, T; Linch, DC; Khwaja, A; (2006) Go6976 is a potent inhibitor of the JAK 2 and FLT3 tyrosine kinases with significant activity in primary acute myeloid leukaemia cells. BRIT J HAEMATOL , 135 (3) 303 - 316. 10.1111/j.1365-2141.2006.06291.x.

Grandage, VL; Everington, T; Linch, DC; Khwaja, A; (2006) Gö6976 is a potent inhibitor of the JAK 2 and FLT3 tyrosine kinases with significant activity in primary acute myeloid leukaemia cells. British Journal of Haematology , 135 (3) pp. 303-316. 10.1111/j.1365-2141.2006.06291.x.

Grasso, A; Stigliano, R; Morisco, F; Martines, H; Quaglia, A; Dhillon, AP; Patch, D; ... Burroughs, AK; + view all (2006) Liver transplantation and recurrent hepatocellular carcinoma: Predictive value of nodule size in a retrospective and explant study. TRANSPLANTATION , 81 (11) 1532 - 1541. 10.1097/01.tp.0000209641.88912.15.

Greaves, LC; Preston, SL; Tadrous, PJ; Taylor, RW; Barron, MJ; Oukrif, D; Leedham, SJ; ... McDonald, SAC; + view all (2006) Mitochondrial DNA mutations are established in human colonic stem cells, and mutated clones expand by crypt fission. Proceedings of the National Academy of Sciences of the United States of America , 103 (3) pp. 714-719. 10.1073/pnas.0505903103.

Greaves, LC; Preston, SL; Tadrous, PJ; Taylor, RW; Barron, MJ; Oukrif, D; Leedham, SJ; ... McDonald, SAC; + view all (2006) Mitochondrial DNA mutations are established in human colonic stem cells, and mutated clones expand by crypt fission. P NATL ACAD SCI USA , 103 (3) 714 - 719. 10.1073/pnas.0505903103.

Green, AJ; Begent, RHJ; (2006) Generation of voxel phantoms to investigate the effect of statistical noise on image analysis programs. In: (pp. S319-).

Green, AJ; Begent, RHJ; (2006) Generation of voxel phantoms to investigate the effect of statistical noise on image analysis programs. EUR J NUCL MED MOL I , 33 S319 - S319.

Gregory, SG; Barlow, KF; McLay, KE; Kaul, R; Swarbreck, D; Dunham, A; Scott, CE; ... Prigmore, E; + view all (2006) The DNA sequence and biological annotation of human chromosome 1. Nature , 441 (7091) pp. 315-321. 10.1038/nature04727.

Gregory, SG; Barlow, KF; Mclay, KE; Kaul, R; Swarbreck, D; Dunham, A; Scott, CE; ... Bentley, DR; + view all (2006) The DNA sequence and biological annotation of human chromosome 1 (vol 441, pg 315, 2006). NATURE , 443 (7114) 1013 - 1013. 10.1038/nature05152.

Gregory, SG; Barlow, KF; Mclay, KE; Kaul, R; Swarbreck, D; Dunham, A; Scott, CE; ... Bentley, DR; + view all (2006) The DNA sequence and biological annotation of human chromosome 1. NATURE , 441 (7091) 315 - 321. 10.1038/nature04727.

Gross, D-A; Chappert, P; Leboeuf, M; Monteilhet, V; Van Wittenberghe, L; Danos, O; Davoust, J; (2006) Simple conditioning with monospecific CD4+CD25+ regulatory T cells for bone marrow engraftment and tolerance to multiple gene products. Blood , 108 (6) pp. 1841-1848. 10.1182/blood-2006-02-011981.

Gupta, A; Saifuddin, A; Briggs, TWR; Flanagan, AM; (2006) Subperiosteal hemangioendothelioma of the femur. SKELETAL RADIOL , 35 (10) 793 - 796. 10.1007/s00256-005-0060-6.

Gupta, N; Saleem, A; Kotz, B; Osman, S; Aboagye, EO; Phillips, R; Vernon, C; ... Price, PM; + view all (2006) Carbogen and nicotinamide increase blood flow and 5-fluorouracil delivery but not 5-fluorouracil retention in colorectal cancer metastases in patients. CLINICAL CANCER RESEARCH , 12 (10) pp. 3115-3123.

Gutierrez-Rodriguez, ME; Sandoval-Ramirez, L; Diaz-Flores, M; Marsh, SGE; Valladares-Salgado, A; Madrigal, JA; Mejia-Arangure, JM; ... Cruz, M; + view all (2006) KIR gene in ethnic and Mestizo populations from Mexico. Human Immunology , 68 pp. 135-146.

Gutierrez-Rodriguez, ME; Sandoval-Ramirez, L; Diaz-Flores, M; Marsh, SGE; Valladares-Salgado, A; Madrigal, JA; Mejia-Arangure, JM; ... Cruz, M; + view all (2006) KIR gene in ethnic and mestizo populations from Mexico. HUMAN IMMUNOLOGY , 67 (1-2) pp. 85-93. 10.1016/j.humimm.2005.11.007.

H

Hackshaw, A; (2006) Smoke gets in your eyes – well only until mid-2007. Significance , 3 (2) pp. 63-65.

Hackshaw, AK; Paul, EA; Davenport, E; (2006) Evidence-based dentistry: an introduction. [Book]. (1st ed.). Blackwell Munksgaard: UK.

Hajioff, D; Hegemann, S; Conti, G; Beck, M; Sunder-Plassmann, G; Widmer, U; Mehta, A; (2006) 6 Agalsidase alpha and hearing in Fabry disease: data from the Fabry Outcome Survey. European Journal of Clinical Investigation , 36 (9) pp. 663-667.

Hamaguchi, A; Suggitt, M; Howard, PW; Gregson, SJ; Kasprzyk, PG; Thurston, DE; Hartley, JA; (2006) DNA cross-linking and in vivo antitumour activity of the extended pyrrolo[2,1-c][1,4]benzodiazepine dimer SG2057 (DRG-16). In: EJC SUPPL. (pp. 96 - 96). PERGAMON-ELSEVIER SCIENCE LTD

Harish, S; Hughes, RJ; Saifuddin, A; Flanagan, AM; (2006) Image-guided percutaneous biopsy of intramedullary lytic bone lesions: utility of aspirated blood clots. EUR RADIOL , 16 (9) 2120 - 2125. 10.1007/s00330-005-0127-8.

Harland, SJ; Daugaard, G; Horwich, A; Mead, GM; Fossa, SD; Sokal, M; Morgenstern, D; ... National, CRITCCSG; + view all (2006) The familial influence on bilateral testicular germ cell cancer: Medical Research Council study TER2. In: (pp. 239S, 4590-).

Harrison, ML; Hoskins, P; du Bois, A; Quinn, M; Rustin, GJS; Ledermann, JA; Baron-Hay, S; (2006) Small cell of the ovary, hypercalcemic type - Analysis of combined experience and recommendation for management. A GCIG study. GYNECOL ONCOL , 100 (2) 233 - 238. 10.1016/j.ygyno.2005.10.024.

Haworth, C; Butcher, LM; Carnell, S; Wardle, J; Plomin, R; (2006) Genetic continuity and change for body mass index in middle childhood. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS , 141B (7) p. 720.

Hayes, MJ; Kimata, Y; Wattam, SL; Lindon, C; Mao, G; Yamano, H; Fry, AM; (2006) Early mitotic degradation of Nek2A depends on Cdc20-independent interaction with the APC/C. Nat. Cell Biol. , 8 (6) pp. 607-614.

Hegemann, S; Hajioff, D; Conti, G; Beck, M; Sunder-Plassmann, G; Widmer, U; Mehta, A; (2006) Hearing loss in Fabry disease: data from the Fabry Outcome Survey. European Journal of Clinical Investigation , 36 (9) pp. 654-662.

Hergovich, A; Lisztwan, J; Thoma, CR; Wirbelauer, C; Barry, RE; Krek, W; (2006) Priming-dependent phosphorylation and regulation of the tumor suppressor pVHL by glycogen synthase kinase 3. MOL CELL BIOL , 26 (15) 5784 - 5796. 10.1128/MCB.00232-06.

Hergovich, A; Schmitz, D; Hemmings, BA; (2006) The human tumour suppressor LATS1 is activated by human MOB1 at the membrane. BIOCHEM BIOPH RES CO , 345 (1) 50 - 58. 10.1016/j.bbrc.2006.03.244.

Hergovich, A; Stegert, MR; Schmitz, D; Hemmings, BA; (2006) NDR kinases regulate essential cell processes from yeast to humans. NAT REV MOL CELL BIO , 7 (4) 253 - 264. 10.1038/nrm1891.

Hing, KA; Revell, PA; Smith, N; Buckland, T; (2006) Effect of silicon level on rate, quality and progression of bone healing within silicate-substituted porous hydroxyapatite scaffolds. Biomaterials , 27 (29) pp. 5014-5026. 10.1016/j.biomaterials.2006.05.039.

Ho, E; Vassileva, V; Lim-Soo, P; Allen, C; Piquette-Miller, M; (2006) Impact of localized, sustained delivery of paclitaxel on the in vitro and in vivo regulation of P-glycoprotein. In: (Proceedings) 107th Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics. (pp. P11-P11). MOSBY, INC

Hollak, CEM; Hughes, D; Schwierin, B; Bembi, B; (2006) IS3: An approach to safety monitoring in daily practice. J INHERIT METAB DIS , 29 42 - 42.

Horton, R; Coggill, P; Miretti, MM; Sambrook, JG; Traherne, JA; Ward, R; Sims, S; ... Beck, S; + view all (2006) The LRC haplotype project: a resource for killer immunoglobulin-like receptor-linked association studies. TISSUE ANTIGENS , 68 (5) 450 - 452. 10.1111/j.1399-0039.2006.00697.x.

Howard, J; Brazma, D; Vaughan, B; Nacheva, EP; (2006) Bi-allelic involvement in AML: Examples of 16q aberrations in two cases. In: BLOOD. (pp. 193B - 193B). AMER SOC HEMATOLOGY

Howard, J; Brazma, D; Vaughan, BR; Nacheva, EP; (2006) Polysomy 8 in CML. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 65 - 65). BLACKWELL PUBLISHING

Howard, PW; Chen, Z; Gregson, SJ; Stephenson, M; Klee, S; Hartley, JM; Subur, G; ... Thurston, DE; + view all (2006) The design, synthesis and biological evaluation of a set of C2-aryl substituted pyrrolo[2,1-c][1,4]benzodiazepine dimers. EJC SUPPL , 4 (12) 95 - 95.

Howard, PW; Tiberghien, A; Gregson, SJ; Kang, GD; Stephenson, M; Kiakos, K; Klee, S; ... Thurston, DE; + view all (2006) Design, synthesis and evaluation of extended heterocycle linked C81C8 ' pyrrolo[2,1-c][1,4]benzodiazepine DNA cross-linking agents. In: EJC SUPPL. (pp. 93 - 93). PERGAMON-ELSEVIER SCIENCE LTD

Hsu, KC; Bignon, JD; Carrington, M; Chida, S; Christiansen, F; De Santis, D; Eljaafari, A; ... Dupont, B; + view all (2006) 13th IHWS NK/KIR Joint Report. Killer immunoglobulin-like receptor genotypes, haplotypes and haplotype segregation patterns evaluated in the workshop KIR reference DNA panel. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 1169-1199). IHWG Press: Seattle.

Hughes, DA; (2006) The use of scoring systems in patients with haematological malignancy. ACTA PAEDIATRICA , 95 47 - 51. 10.1080/08035320600618866.

Hughes, DA; Reed, M; Baker, RJ; Richfield, L; Milligan, A; Evans, S; Blincoe, M; ... Mehta, A; + view all (2006) Enhanced differentiation of osteoclasts from mononuclear precursors in patients with Gaucher disease. J INHERIT METAB DIS , 29 21 - 21.

Hughes, R; Glynne-Jones, R; Grainger, J; Richman, P; Makris, A; Harrison, M; Ashford, R; ... Novell, JR; + view all (2006) Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision? International Journal of Colorectal Disease , 21 (1) pp. 11-17.

I

Ings, SJ; Balsa, C; Leverett, D; Mackinnon, S; Linch, DC; Watts, MJ; (2006) Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used. BRIT J HAEMATOL , 134 (5) 517 - 525. 10.1111/j.1365-2141.2006.06223.x.

Islam, L; Amary, MF; Idowu, B; Diss, T; Flanagan, AM; (2006) Frequent detection of beta-catenin gene mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion. In: (Proceedings) 190th Meeting of the Pathological-Society-of-Great-Britain-and-Ireland. (pp. p. 26). JOHN WILEY & SONS LTD

J

Jacobs, IJ; Mackay, J; Menon, U; Skates, SJ; Rosenthal, AN; Fraser, L; (2006) Familial ovarian screening - effective or ineffective? BRIT J CANCER , 95 (8) 1124 - 1124. 10.1038/sj.bjc.6603407.

Jacobs, IJ; Mackay, J; Menon, U; Skates, SJ; Rosenthal, AN; Fraser, L; (2006) Familial ovarian screening--effective or ineffective? British Journal of Cancer , 23 (9) pp. 1126-1127.

Jagsi, R; Makris, A; Goldberg, S; Taghian, A; (2006) Intra-European differences in the radiotherapeutic management of breast cancer: A survey study. CLINICAL ONCOLOGY , 18 (5) pp. 369-375.

Jell, G; Kerjaschki, D; Revell, P; Al-Saffar, N; (2006) Lymphangiogenesis in the bone-implant interface of orthopedic implants: importance and consequence. J BIOMED MATER RES A , 77A (1) 119 - 127. 10.1002/jbm.a.30548.

Jellinek, DA; Levy, D; Maltby, E; Atkey, N; Hibberd, S; Crimmins, D; Stoeber, K; ... Wharton, SB; + view all (2006) Cytogenetic subtypes of oligodendroglioma differ in their apoptotic index, while the population of replication-licensed, non-proliferating cells is higher in anaplastic tumors but does not differ according to 1p,19q status. In: NEURO-ONCOLOGY. (pp. 459 - 459). DUKE UNIV PRESS

Jenkins, V; Shilling, V; Deutsch, G; Bloomfield, D; Morris, R; Allan, S; Bishop, H; ... Winstanley, J; + view all (2006) A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer , 94 (6) pp. 828-834. 10.1038/sj.bjc.6603029.

Jennings, BH; Pickles, LM; Wainwright, SM; Roe, SM; Pearl, LH; Ish-Horowicz, D; (2006) Molecular recognition of transcriptional repressor motifs by the WD domain of the Groucho/TLE corepressor. Mol Cell , 22 (5) pp. 645-655. 10.1016/j.molcel.2006.04.024.

Jones, RL; Swanton, C; Ewer, MS; (2006) Anthracycline cardiotoxicity. Expert Opin Drug Saf , 5 (6) pp. 791-809. 10.1517/14740338.5.6.791.

Jones, SF; Plummer, ER; Burris, HA; Razak, AR; Meluch, AA; Bowen, CJ; Williams, DH; ... Calvert, AH; + view all (2006) Phase I study of ispinesib in combination with carboplatin in patients with advanced solid tumors. JOURNAL OF CLINICAL ONCOLOGY , 24 (18) 85S - 85S.

Jones, SF; Plummer, ER; Burris, HA; Razak, AR; Meluch, AA; Bowen, CJ; Williams, DH; ... Calvert, AH; + view all (2006) Phase I study of ispinesib in combination with carboplatin in patients with advanced solid tumors. J Clin Oncol , 24 (18_suppl) 2027-.

Juergens, C; Weston, C; Lewis, I; Whelan, J; Paulussen, M; Oberlin, O; Michon, J; ... Craft, A; + view all (2006) Safety Assessment of Intensive Induction With Vincristine, Ifosfamide, Doxorubicin, and Etoposide (VIDE) in the Treatment of Ewing Tumors in the EURO-E.W.I.N.G. 99 Clinical Trial. Pediatric Blood and Cancer , 47 (1) pp. 22-29.

Julia, LS; (2006) You Don't Have to Smoke to Get Lung Cancer. Sunday Telegraph, Stella Magazine

K

Kakourou, G; Dhanjal, S; Sud, R; Mamas, T; Doshi, A; Nuttall, S; Gotts, S; ... SenGupta, S; + view all (2006) Preimplantation genetic diagnosis for non-syndrornic deafness. In: JOURNAL OF MEDICAL GENETICS. (pp. S58 - S58). B M J PUBLISHING GROUP

Kalve, I; Devitt, D; Little, AM; Liu, X; Tilanus, M; Marsh, SGE; Madrigal, JA; (2006) Evaluation of RSCA® as a novel, emerging HLA typing method. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 295-303). IHWG Press: Seattle.

Kang, S; Denley, A; Vanhaesebroeck, B; Vogt, PK; (2006) Oncogenic transformation induced by the p110 beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , 103 (5) pp. 1289-1294. 10.1073/pnas.0510772103.

Karavolos, S; Caplin, M; Benjamin, E; Crow, J; Mould, T; (2006) Primary mucinous carcinoid tumour of the ovary: a case report. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , 27 (6) pp. 618-620.

Kaufmann, M; Hortobagyi, GN; Goldhirsch, A; Scholl, S; Makris, A; Valagussa, P; Blohmer, JU; ... von Minckwitz, G; + view all (2006) Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: An update. JOURNAL OF CLINICAL ONCOLOGY , 24 (12) pp. 1940-1949.

Khan, K; Stubbs, M; Shah, T; Savage, K; Dhillon, AP; Caplin, ME; (2006) Gastrin and CCK2 processing in neuroendocrine tumours and cell lines: Therapeutic targets. In: GUT. (pp. A9 - A10). B M J PUBLISHING GROUP

Khanduri, S; Gerrard, G; Barton, R; Mulvenna, P; Lee, SM; (2006) Clinical trials assessing the optimal management of brain metastases - The state of play. CLINICAL ONCOLOGY , 18 (10) pp. 744-746. 10.1016/j.clon.2006.08.009.

Khoja, L; Mulyati, M; Lee, SM; (2006) Secondline chemotherapy in NSCLC. Lung Cancer in Practice , 3 (1) pp. 6-7.

Khwaja, A; (2006) The role of Janus kinases in haemopoiesis and haematological malignancy. BRIT J HAEMATOL , 134 (4) 366 - 384. 10.1111/j.1365-2141.2006.06206.x.

Kim, BS; Miyagawa, F; Bennett, CL; Clausen, BE; Katz, SI; (2006) Elimination of epidermal Langerhans cells or impairment of dermal dendritic cells does not abrogate the induction of localized graft-versus-host-disease-like skin disease. In: (Proceedings) 67th Annual Meeting of the Society-for-Investigative-Dermatology. (pp. p. 119). NATURE PUBLISHING GROUP

Kimata, Y; Yamano, H; (2006) Structural analysis sheds light on APC/C-mediated ubiquitylation. Dev. Cell , 10 (1) pp. 4-5.

Kleinert, J; Dehout, F; Schwarting, A; de, LAG; Ricci, R; Kampmann, C; Beck, M; ... Sunder-Plassmann, G; + view all (2006) Prevalence of uncontrolled hypertension in patients with Fabry disease. American Journal of Hypertension , 19 (8) pp. 782-787.

Klupsch, K; Downward, J; (2006) The protease inhibitor Ucf-101 induces cellular responses independently of its known target, HtrA2/Omi. CELL DEATH DIFFER , 13 (12) 2157 - 2159. 10.1038/sj.cdd.4401955.

Kluza, J; Mazinghien, R; Irwin, H; Hartley, JA; Bailly, C; (2006) Relationships between DNA strand breakage and apoptotic progression upon treatment of HL-60 leukemia cells with tafluposide or etoposide. ANTI-CANCER DRUG , 17 (2) 155 - 164.

Kocjan, G; (2006) What is the role of fine needle aspiration cytology in the multidisciplinary approach to breast carcinoma. In: Drinkovic, I, (ed.) Proceedings of the XIV World Congress on Breast Diseases. (pp. 105 - 108). MEDIMOND S R L

Kocjan, G; (2006) Fine Needle aspiration Cytology; Diagnostic Principles and Dilemmas. [Book]. (Vol.1). (1 vols). (1 ed.). Springer -Verlag Berlin Heidelberg: Germany.

Kocjan, G; Feichter, G; Hagmar, B; Kapila, K; Kardum-Skelin, I; Kloboves, V; Kobayashi, TK; ... Herbert, A; + view all (2006) Fine needle aspiration cytology: a survey of current European practice. CYTOPATHOLOGY , 17 (5) 219 - 226.

Kogelberg, H; Sharma, SK; Qureshi, U; Tolner, B; Lowdell, M; Shabakhti, H; Robson, M; ... Chester, KA; + view all (2006) Clearance mechanism of a mannoseylated antibody enzyme fusion protein used in experimental cancer therapy. In: (Proceedings) NCRI Cancer Conference Proceedings. (pp. 65-).

Kogelberg, H; Sharma, SK; Qureshi, U; Tolner, B; Lowdell, M; Shahbakhti, H; Robson, M; ... Chester, KA; + view all (2006) Clearance Mechanism Of A Mannosylated Antibody-Enzyme Fusion Protein Used In Experimental Cancer Therapy. In: (Proceedings) NCRI Cancer Conference Proceedings.

Korman, AJ; Peggs, KS; Allison, JP; (2006) Checkpoint blockade in cancer immunotherapy. ADV IMMUNOL , 90 297 - 339. 10.1016/S0065-2776(06)90008-X.

Koukourakis, M.I.; Bentzen, S.M.; Giatromanolaki, A.; Wilson, G.D.; Daley, F.M.; Saunders, M.I.; Dische, S.; ... Harris, A.L.; + view all (2006) Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. Journal of Clinical Oncology , 24 (5) pp. 727-735. 10.1200/jco.2005.02.7474.

Koukourakis, MI; Bentzen, SM; Giatromanolaki, A; Wilson, GD; Daley, FM; Saunders, MI; Dische, S; ... Harris, AL; + view all (2006) Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. J Clin Oncol , 24 (5) pp. 727-735. 10.1200/JCO.2005.02.7474.

Krishnan, SP; Skinner, JA; Bartlett, W; Carrington, RW; Flanagan, AM; Briggs, TW; Bentley, G; (2006) Who is the ideal candidate for autologous chondrocyte implantation? Journal of Bone and Joint Surgery - Series B , 88 (1) pp. 61-64.

Krishnan, SP; Skinner, JA; Carrington, RW; Flanagan, AM; Briggs, TW; Bentley, G; (2006) Collagen-covered autologous chondrocyte implantation for osteochondritis dissecans of the knee: TWO- TO SEVEN-YEAR RESULTS. Journal of Bone and Joint Surgery - Series B , 88 (2) pp. 203-205.

Krutzfeldt, M; Broceno, C; Ellis, M; Weekes, DB; Bull, JJ; Sellers, WR; Eilers, M; ... Mittnacht, S; + view all (2006) Selective ablation of retinoblastoma protein function by the RET finger protein. In: (pp. p. 98).

Kyriakou, C; Davies, M; Chatterjee, R; Castleton, A; Roberts, K; Peniket, A; Mackinnon, S; (2006) Female gonadal function following reduced intensity conditioning (RIC) allogeneic bone marrow transplantation for haematological malignancies. In: BLOOD. (pp. 962A - 963A). AMER SOC HEMATOLOGY

Kyriakou, C; Rabin, N; Nathwani, A; Pizzey, A; Linch, DC; Yong, K; (2006) Factors influencing short term in vivo biodistribution of human bone marrow derived mesenchymal stem cells (hMSCs) in a xenogeneic animal model. In: BLOOD. (pp. 908A - 908A). AMER SOC HEMATOLOGY

Kyriakou, CA; Yong, KL; Benjamin, R; Pizzey, A; Dogan, A; Singh, N; Davidoff, AM; (2006) Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral-mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model. J GENE MED , 8 (3) 253 - 264. 10.1002/jgm.840.

L

Ladenstein, R; Whelan, J; Oberlin, O; Weston, C; Jurgens, H; (2006) Multivariate analysis based risk grouping of Ewing tumours with extrapulmonary metastatic disease. Results from the EURO EWING 99 Study. In:

Lagging, M; Romero, AI; Westin, J; Norkrans, G; Dhillon, AP; Pawlotsky, JM; Zeuzem, S; ... DITTO-HCV Study Grp, ; + view all (2006) IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection. HEPATOLOGY , 44 (6) 1617 - 1625. 10.1002/hep.21407.

Lai, CSL; Boshoff, C; Falzon, M; Lee, SM; (2006) Complete response to erlotinib treatment in brain metastases from recurrent NSCLC. UNSPECIFIED

Lai, CSL; Boshoff, C; Falzon, M; Lee, SM; (2006) Complete response to erlotinib treatment in brain metastases from recurrent NSCLC. THORAX , 61 (1) 91 - 91. 10.1136/thx.2005.052233.

Lai, CSL; Boshoff, C; Falzon, M; Lee, SM; (2006) Complete response to erlotinib treatment in brain metastases from recurrent NSCLC [1]. Thorax , 61 (1) 91-. 10.1136/thx.2005.052233.

Lam, L; Berisha, F; Diss, TC; Flanagan, AM; (2006) Formalin-fixed paraffin-embedded material is a reliable source of RNA for molecular genetic analysis provided small fragments are targeted. In: (Proceedings) 190th Meeting of the Pathological-Society-of-Great-Britain-and-Ireland. (pp. p. 6). WILEY-BLACKWELL

Lambros, MBK; Simpson, PT; Jones, C; Natrajan, R; Westbury, C; Steele, D; Savage, K; ... Reis-Filho, JS; + view all (2006) Unlocking pathology archives for molecular genetic studies: a reliable method to generate probes for chromogenic and fluorescent in situ hybridization. Lab Invest , 86 (4) pp. 398-408. 10.1038/labinvest.3700390.

Last, K; Maharaj, L; Perry, J; Strauss, S; Fitzgibbon, J; Lister, TA; Joel, S; (2006) The activity of methylated and non-methylated selenium species in lymphoma cell lines and primary tumours. Ann Oncol , 17 (5) 773-9-773-9.

Laun, K; Coggill, P; Palmer, S; Sims, S; Ning, ZM; Ragoussis, J; Volpi, E; ... Volz, A; + view all (2006) The leukocyte receptor complex in chicken is characterized by massive expansion and diversification of immunoglobulin-like loci. PLoS Genetics , 2 (5) , Article e73. 10.1371/journal.pgen.0020073. Green open access
file

Laurent, C; Quaglia, A; Foroni, L; Bioulac-Sage, P; Balabaud, C; Dhillon, AP; (2006) Genomic alteration is not associated with fatty and clear cell change in hepatocellular carcinomas and its precursor nodular lesions in cirrhotic liver. HEPATOL RES , 36 (1) 40 - 47. 10.1016/j.hepres.2006.06.003.

Lawrie, AS; Cardigan, R; Williamson, LW; Machin, SJ; Mackie, IJ; (2006) Fresh-frozen plasma (FFP) quality assessed by dynamics of the clotting process. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 118 - 119). BLACKWELL PUBLISHING

Lawrie, CH; Marafioti, T; Hatton, CSR; Dirnhofer, S; Roncador, G; Went, P; Tzankov, A; ... Banham, AH; + view all (2006) Cancer-associated carbohydrate identification in Hodgkin's lymphoma by carbohydrate array profiling. Int J Cancer , 118 (12) pp. 3161-3166. 10.1002/ijc.21762.

Le, NM; Sielaff, AM; Cooper, AJ; Mackay, H; Brown, T; Kotecha, M; O'Hare, C; ... Hartley, JA; + view all (2006) Binding of f-PIP, a pyrrole- and imidazole-containing triamide to the inverted CCAAT box-2 of the topoisomerase II alpha promoter and modulation of gene expression in cells. Bioorganic and Medicinal Chemistry Letters , 16 (24) pp. 1661-1664.

Le, NM; Sielaff, AM; Cooper, AJ; Mackay, H; Brown, T; Kotecha, M; O'Hare, C; ... Hartley, JA; + view all (2006) Binding of f-PIP, a pyrrole- and imidazole-containing triamide to the inverted CCAAT box-2 of the topoisomerase II alpha promoter and modulation of gene expression in cells. BIOORG MED CHEM LETT , 16 (24) 6161 - 6164. 10.1016/j.bmcl.2006.09.043.

Le Sann, C; Baron, A; Mann, J; van den Berg, H; Gunaratnam, M; Neidle, S; (2006) New mustard-linked 2-aryl-bis-benzimidazoles with anti-proliferative activity. Org Biomol Chem , 4 (7) pp. 1305-1312. 10.1039/b600567e.

Ledermann, JA; Raja, F; (2006) Management strategies for partially platinum-sensitive ovarian cancer. American Journal of Cancer , 5 (5) pp. 341-354. 10.2165/00024669-200605050-00005.

Lee, SM; (2006) Is EGFR expression important in non-small cell lung cancer? Thorax , 61 (2) pp. 98-99.

Lee, TI; Jenner, RG; Boyer, LA; Guenther, MG; Levine, SS; Kumar, RM; Chevalier, B; ... Young, RA; + view all (2006) Control of developmental regulators by Polycomb in human embryonic stem cells. Cell , 125 (2) pp. 301-313. 10.1016/j.cell.2006.02.043.

Lee, YK; Shanafelt, T; Chan, D; Giaccia, A; Mukhopadhyay, D; Taccioli, C; Calin, G; ... Kay, NE; + view all (2006) Elevated HIF-1 alpha levels in CLLB cells may explain their autocrine VEGF secretion. In: BLOOD. (pp. 176A - 176A). AMER SOC HEMATOLOGY

Lehmann, DJ; Barnardo, MCNM; Fuggle, S; Quiroga, I; Sutherland, A; Warden, DR; Barnetson, L; ... Smith, AD; + view all (2006) Replication of the association of HLA-B7 with Alzheimer's disease: a role for homozygosity? J NEUROINFLAMM , 3 , Article 33. 10.1186/1742-2094-3-33. Green open access
file

Lidove, O; Ramaswami, U; Jaussaud, R; Barbey, F; Maisonobe, T; Caillaud, C; Beck, M; ... Mehta, AFOSEI; + view all (2006) Hyperhidrosis: a new and often early symptom in Fabry disease. International experience and data from the Fabry Outcome Survey. International Journal of Clinical Practice , 60 (9) pp. 1053-1059.

Lieb, JD; Beck, S; Bulyk, ML; Farnham, P; Hattori, N; Henikoff, S; Liu, XS; ... Greally, JM; + view all (2006) Applying whole-genome studies of epigenetic regulation to study human disease. CYTOGENET GENOME RES , 114 (1) 1 - 15. 10.1159/000091922.

Liobikas, J; Polianskyte, Z; Speer, O; Thompson, J; Alakoskela, J-M; Peitsaro, N; Franck, M; ... Eriksson, O; + view all (2006) Expression and purification of the mitochondrial serine protease LACTB as an N-terminal GST fusion protein in Escherichia coli. Protein Expression and Purification , 45 (2) pp. 335-342. 10.1016/j.pep.2005.08.006.

Liso, A; Capello, D; Marafioti, T; Tiacci, E; Cerri, M; Distler, V; Paulli, M; ... Falini, B; + view all (2006) Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma. Blood , 108 (3) pp. 1013-1020. 10.1182/blood-2005-10-3949.

Longair, I; Gardiner, C; Pescott, MA; Erwin, H; Mackie, IJ; Machin, SJ; (2006) An evaluation of HemoSense (TM) INRatio prothrombin time monitoring system. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 40 - 40). BLACKWELL PUBLISHING

Lopez, M; Aguilera, R; Perez, C; Mendoza-Naranjo, A; Pereda, C; Ramirez, M; Ferrada, C; ... Salazar-Onfray, F; + view all (2006) The role of regulatory T lymphocytes in the induced immune response mediated by biological vaccines. IMMUNOBIOLOGY , 211 (1-2) 127 - 136. 10.1016/j.imbio.2005.11.003.

Louise, J; (2006) Thalidomide makes a comeback-but at what cost? Morning Star

Lovat, LB; Johnson, K; Mackenzie, GD; Clark, BR; Novelli, MR; Davies, S; O'Donovan, M; ... Bown, SG; + view all (2006) Elastic scattering spectroscopy accurately detects high grade dysplasia and cancer in Barrett's oesophagus. Gut , 55 (8) pp. 1078-1083. 10.1136/gut.2005.081497. Gold open access

Lovell, R; Delgado, J; Thomson, K; Russell, N; Ewing, J; Stewart, W; Marks, D; ... Milligan, D; + view all (2006) Results of alemtuzumab-based reduced-intensity allogeneic transplantation for advanced chronic lymphocytic leukaemia: a BSBMT study. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 66 - 67). BLACKWELL PUBLISHING

Lowdell, MW; Bakhsh, I; North, J; Marden, C; Addison, E; Mackinnon, S; (2006) Tumor-activated human NK cells specificall ylyse autologous and allogeneic NK-resistant tumor targets. In: BLOOD. (pp. 1059A - 1059A). AMER SOC HEMATOLOGY

M

MacGregor, EA; Frith, A; Ellis, J; Aspinall, L; Hackshaw, A; (2006) Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology , 67 (12) pp. 2154-2158.

MacGregor, EA; Frith, A; Ellis, J; Aspinall, L; Hackshaw, A; (2006) Prevention of menstrual attacks of migraine - A double-blind placebo-controlled crossover study. Neurology , 67 (12) pp. 2159-2163.

Maharaj, L; Popat, R; Chahwan, A; Lister, AT; Cavenagh, JD; Middleton, B; Rioja, A; ... Joel, SP; + view all (2006) The novel HDAC inhibitor UCL67022 is highly potent in multiple myeloma and non-Hodgkin's lymphoma and is enhanced by bortezomib. In: (Proceedings) 48th Annual Meeting of the American-Society-of-Hematology. (pp. 735A-735A). AMER SOC HEMATOLOGY

Mansour, MR; (2006) A role for aberrant Notch signaling in acute myeloid leukemia? LEUKEMIA & LYMPHOMA , 47 (11) pp. 2280-2281. 10.1080/10428190600908109.

Mansour, MR; Linch, DC; Foroni, L; Goldstone, AH; (2006) High incidence of Notch-1 mutations in adult patients with T-cell acute lymphoblastic leukemia. LEUKEMIA , 20 (3) 537 - 539. 10.1038/sj.leu.2404101.

Mansour, MR; Linch, DC; Foroni, L; Goldstone, AH; Gale, RE; (2006) High incidence of Notch-1 mutations in adult patients with T-cell acute lymphoblastic leukemia [12]. Leukemia , 20 (3) pp. 537-539. 10.1038/sj.leu.2404101.

Mantovani, J; Holic, N; Martinez, K; Danos, O; Perea, J; (2006) A high throughput method for genome-wide analysis of retroviral integration. Nucleic Acids Res , 34 (19) , Article e134. 10.1093/nar/gkl716.

Marafioti, T; Mason, DY; (2006) Diagnostic Immunohistopathology. Monoclonal Antibodies as Therapeutic Agents. [Digital scholarly resource]. http://www.hstalks.com/mono/index.htm

Marelli, L; Stigliano, R; Triantos, C; Senzolo, M; Cholongitas, E; Davics, N; Tibbals, J; ... Burroughs, A; + view all (2006) Transarterial therapy for hepatocellular carcinoma (HCC) in cirrhosis: Is embolization as effective as chemoembolization? Systematic review of cohort and randomized studies. In: (Proceedings) 41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver. (pp. S106-S106). ELSEVIER SCIENCE BV

Marelli, L; Stigliano, R; Triantos, C; Senzolo, M; Cholongitas, E; Davies, N; Yu, D; ... Burroughs, AK; + view all (2006) Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies. Cancer Treat Rev , 32 (8) pp. 594-606. 10.1016/j.ctrv.2006.08.002.

Marks, DJB; Harbord, MWN; MacAllister, R; Rahman, FZ; Young, J; Al-Lazikani, B; Lees, W; ... Segal, AW; + view all (2006) Defective acute inflammation in Crohn's disease: a clinical investigation. LANCET , 367 (9511) 668 - 678.

Markusen, JF; Mason, C; Hull, DA; Town, MA; Tabor, AB; Clements, M; Boshoff, CH; (2006) Behavior of adult human mesenchymal stem cells entrapped in alginate-GRGDY beads. TISSUE ENG , 12 (4) 821 - 830.

Marquis, J; Paillard, L; Audic, Y; Cosson, B; Danos, O; Le Bec, C; Osborne, HB; (2006) CUG-BP1/CELF1 requires UGU-rich sequences for high-affinity binding. Biochem J , 400 (2) pp. 291-301. 10.1042/BJ20060490.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, February 2006 update. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 33 (3) pp. 227-228. 10.1111/j.1744-313X.2006.00590.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, January 2006 update. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 33 (3) pp. 225-226. 10.1111/j.1744-313X.2006.00589.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, October 2005 update*. Int J Immunogenet , 33 (1) pp. 63-64. 10.1111/j.1744-313X.2006.00566.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update April 2006. TISSUE ANTIGENS , 68 (3) pp. 270-272. 10.1111/j.1399-0039.2006.00655.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update August 2006. TISSUE ANTIGENS , 68 (6) pp. 537-539. 10.1111/j.1399-0039.2006.00711.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update December 2005. TISSUE ANTIGENS , 67 (3) pp. 262-264. 10.1111/j.1399-0039.2006.00564.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update December 2005. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 33 (2) pp. 147-149. 10.1111/j.1744-313X.2006.00576.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update February 2006. TISSUE ANTIGENS , 67 (5) pp. 440-442. 10.1111/j.1399-0039.2006.00601.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update January 2006. TISSUE ANTIGENS , 67 (5) pp. 438-439. 10.1111/j.1399-0039.2006.00597.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update July 2006. HUMAN IMMUNOLOGY , 67 (12) pp. 1017-1018. 10.1016/j.humimm.2006.10.001.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update July 2006. TISSUE ANTIGENS , 68 (6) pp. 535-536. 10.1111/j.1399-0039.2006.00709.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update June 2006. TISSUE ANTIGENS , 68 (3) pp. 276-277. 10.1111/j.1399-0039.2006.00659.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update March 2006. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 33 (3) pp. 229-230. 10.1111/j.1744-313X.2006.00602.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update March 2006. TISSUE ANTIGENS , 68 (1) pp. 100-102. 10.1111/j.1399-0039.2006.00617.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update May 2006. TISSUE ANTIGENS , 68 (3) pp. 273-275. 10.1111/j.1399-0039.2006.00660.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update November 2005. TISSUE ANTIGENS , 67 (3) pp. 260-261. 10.1111/j.1399-0039.2006.00561.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update November 2005. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 33 (2) pp. 145-146. 10.1111/j.1744-313X.2006.00575.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update October 2005. TISSUE ANTIGENS , 67 (3) pp. 258-259. 10.1111/j.1399-0039.2005.00545.x.

Marsh, SGE; (2006) Nomenclature for Factors of the HLA system, update July 2002 to August 2004. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 38-46). IHWG Press: Seattle.

Marsh, SGE; Parham, P; Dupont, B; Geraghty, DE; Trowsdale, J; Middleton, D; Vilches, C; ... Wain, H; + view all (2006) Killer-cell Immunoglobulin-like Receptor (KIR) Nomenclature Report, 2002. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 1196-1202). IHWG Press: Seattle.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2006) Nomenclature for factors of the HLA system, update September 2006. Tissue Antigens , 68 (6) pp. 540-542. 10.1111/j.1399-0039.2006.00713.x.

Masir, N; Marafioti, T; Jones, M; Natkunam, Y; Rdiger, T; Hansmann, M-L; Mason, DY; (2006) Loss of CD19 expression in B-cell neoplasms. Histopathology , 48 (3) pp. 239-246. 10.1111/j.1365-2559.2005.02317.x.

Mason, AJ; Martinez, A; Glaubitz, C; Danos, O; Kichler, A; Bechinger, B; (2006) The antibiotic and DNA-transfecting peptide LAH4 selectively associates with, and disorders, anionic lipids in mixed membranes. FASEB J , 20 (2) pp. 320-322. 10.1096/fj.05-4293fje.

Masterson, LA; Spanswick, VJ; Hartley, JA; Begent, RH; Howard, PW; Thurston, DE; (2006) Synthesis and biological evaluation of novel pyrrolo[2,1-c][1,4]benzodiazepine prodrugs for use in antibody-directed enzyme prodrug therapy. BIOORG MED CHEM LETT , 16 (2) 252 - 256. 10.1016/j.bmcl.2005.10.017.

Masterson, LA; Spanswick, VJ; Hartley, JA; Begent, RH; Howard, PW; Thurston, DE; (2006) Synthesis and biological evaluation of novel pyrrolo[2,1-c][1,4]benzodiazepine prodrugs for use in antibody-directed enzyme prodrug therapy. Bioorganic and Medicinal Chemistry Letters , 16 (2) pp. 252-256. 10.1016/j.bmcl.2005.10.017.

Mayer, A; Francis, RJ; Sharma, SK; Tolner, B; Springer, CJ; Martin, J; Boxer, GM; ... Begent, RH; + view all (2006) A Phase I Study of Single Administration of Antibody-Directed Enzyme Prodrug Therapy with the Recombinant Anti-Carcinoembryonic Antigen Antibody-Enzyme Fusion Protein MFECP1 and a Bis-Iodo Phenol Mustard Prodrug. Clinical Cancer Research , 12 (21) pp. 6509-6516.

Mayer, A; Francis, RJ; Sharma, SK; Tolner, B; Springer, CJ; Martin, J; Boxer, GM; ... Begent, RHJ; + view all (2006) A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrug. CLIN CANCER RES , 12 (21) 6509 - 6516. 10.1158/1078-0432.CCR-06-0769.

Mayor, NP; Shaw, BE; Derralynn, AH; Maldonado-Torres, H; Madrigal, JA; Keshav, S; Marsh, SGE; (2006) Single nucleotide polymorphisms of the NOD2/CARD15 gene are associated with significant increases in disease relapse and mortality in recipients of an unrelated donor haematopoietic stem cell transplant for acute leukaemia. In: BLOOD. (pp. 151A - 151A). AMER SOC HEMATOLOGY

McCarville, MB; Streck, CJ; Dickson, PV; Li, CS; Nathwani, AC; Davidoff, AM; (2006) Angiogenesis inhibitors in a murine neuroblastoma model: Quantitative assessment of intratumoral blood flow with contrast-enhanced gray-scale US. RADIOLOGY , 240 (1) 73 - 81. 10.1148/radiol.2401050709.

McCarville, MB; Streck, CJ; Dickson, PV; Li, CS; Nathwani, AC; Davidoff, AM; (2006) Angiogenesis inhibitors in a murine neuroblastoma model: Quantitative assessment of intratumoral blood flow with contrast-enhanced gray-scale US. Radiology , 240 (1) pp. 73-81. 10.1148/radiol.2401050709.

McDonald, S; Greaves, LG; Leedham, SJ; Preston, SL; Taylor, RW; Oukrif, D; Deheragoda, M; ... Wright, NA; + view all (2006) Monoclonal conversion in human gastric glands: Insights into stem cell and clonal architecture. In: JOURNAL OF PATHOLOGY. (pp. 29A - 29A). JOHN WILEY & SONS LTD

McDonald, SAC; Greaves, LG; Leedham, SJ; Yin-Lee, C; Deheragoda, M; Oukrif, D; Novelli, MR; ... Wright, NA; + view all (2006) Monoclonal conversion of human gastric glands provides insights into stem cell and clonal architecture. In: GUT. (pp. A28 - A28). B M J PUBLISHING GROUP

McGurk, CJ; Cummings, M; Koberle, B; Hartley, JA; Oliver, RT; Masters, JR; (2006) Regulation of DNA repair gene expression in human cancer cell lines. J CELL BIOCHEM , 97 (5) 1121 - 1136. 10.1002/jcb.20711.

McIntosh, JH; Cochrane, M; Prizzey, A; Waldmann, H; Davidoff, AM; Nathwani, AC; (2006) Successful Readministration of AAV8 Following Administration of Nondepleting CD4 Antibody at the Time of Vector Administration. MOLECULAR THERAPY , 13 S190-S190.

McTiernan, A; Driver, D; Michelagnoli, MP; Kilby, AM; Whelan, JS; (2006) High dose chemotherapy with bone marrow or peripheral stem cell rescue is an effective treatment option for patients with relapsed or progressive Ewing's sarcoma family of tumours. ANN ONCOL , 17 (8) 1301 - 1305. 10.1093/annonc/mdl108.

McTiernan, A; Meyer, T; Michelagnoli, MP; Lewis, I; Whelan, JS; (2006) A phase I/II study of doxorubicin, ifosfamide, etoposide and interval methotrexate in patients with poor prognosis osteosarcoma. PEDIATR BLOOD CANCER , 46 (3) 345 - 350. 10.1002/pbc.20562.

McTiernan, A; Whelan, J; Leahy, M; Woll, PJ; Judson, I; (2006) A phase II nonrandomised open-label study of liposomal daunorubicin (DaunoXome) in advanced soft tissue sarcoma. Sarcoma , 2006 10.1155/SARCOMA/41080. Gold open access

McTiernan, AM; Cassoni, AM; Driver, D; Michelagnoli, MP; Kilby, AM; Whelan, JS; (2006) Improving Outcomes After Relapse in Ewing’s Sarcoma: Analysis of 114 Patients From a Single Institution. Sarcoma , 2006 pp. 1-8. Gold open access

Mcintosh, J; Cochrane, M; Tuddenham, EGD; Davidoff, AM; Nathwani, AC; (2006) Expression of human FIX at therapeutic levels in nonhuman primates following a single peripheral vein infusion of low doses of self complementary AAV vector renews hope for haemophilia B gene therapy. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 18 - 18). BLACKWELL PUBLISHING

Meaburn, E; Butcher, LM; Schalkwyk, LC; Plomin, R; (2006) Genotyping pooled DNA using 100K SNP microarrays: a step towards genomewide association scans. Nucleic Acids Res. , 34 (4) , Article e27. 10.1093/nar/gnj027.

Mead, AJ; Linch, DC; Hills, R; Wheatley, K; Burnett, AK; Gale, RE; (2006) The favourable prognostic impact of tyrosine kinase domain mutations of FLT3 in AML is related to the level of mutation. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 106 - 106). BLACKWELL PUBLISHING

Mehta, A; (2006) Clinical experience with substrate reduction therapy. European Journal of Internal Medicine , 17 S13-15.

Mehta, A; (2006) Epidemiology and natural history of Gaucher's disease. European Journal of Internal Medicine (17) S2-S5.

Mickelson, E; Hurley, C; Ng, J; Tilanus, M; Carrington, M; Marsh, SGE; Rozemuller, E; ... Hansen, J; + view all (2006) 13th IHWS Shared Resources Joint Report. IHWG Cell and Gene Bank and reference cell panels. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 523-553). IHWG Press: Seattle.

Middleton, D; Meenagh, A; Marsh, SGE; Martin, J; (2006) A HLA-Cw*03 allele, Cw*0322Q with limited or no expression. TISSUE ANTIGENS , 67 (4) pp. 343-345. 10.1111/j.1399-0039.2006.00571.x.

Middleton, M.R.; Ranson, M.; Lee, S.M.; Bridgewater, J.A.; (2006) Phase I study of 4-bromothenylguanine (4-BTG, PaTrin 2), an alkyltransferase inactivator and temozolomide. Clinical Cancer Research , 6 (Suppl.) 538a.

Milligan, A; Hughes, D; Goodwin, S; Richfield, L; Mehta, A; (2006) Intravenous enzyme replacement therapy: better in home or hospital? British Journal of Nursing , 15 (6) pp. 330-333.

Miretti, MM; Beck, S; (2006) Immunogenomics: molecular hide and seek. Hum Genomics , 2 (4) pp. 244-251.

Miro, F; Nobile, C; Blanchard, N; Lind, M; Filipe-Santos, O; Fieschi, C; Chapgier, A; ... Hivroz, C; + view all (2006) T cell-dependent activation of dendritic cells requires IL-12 and IFN-gamma signaling in T cells. J Immunol , 177 (6) pp. 3625-3634.

Mita, MM; Ochoa, L; Rowinsky, EK; Kuhn, J; Schwartz, G; Hammond, LA; Patnaik, A; ... Cunningham, D; + view all (2006) A Phase I, pharmacokinetic and biologic correlative study of oblimersen sodium (GenasenseTM, G3139) and irinotecan in patients with metastatic colorectal cancer. Advances in Gastrointestinal Cancers , 4 (1) pp. 20-21.

Montaner, D; Tarraga, J; Huerta-Cepas, J; Burguet, J; Vaquerizas, JM; Conde, L; Minguez, P; ... Dopazo, J; + view all (2006) Next station in microarray data analysis: GEPAS. NUCLEIC ACIDS RESEARCH , 34 W486-W491. 10.1093/nar/gkl197. Gold open access

Moore, MJB; Schultes, CM; Cuesta, J; Cuenca, F; Gunaratnam, M; Tanious, FA; Wilson, WD; (2006) Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation. J Med Chem , 49 (2) pp. 582-599. 10.1021/jm050555a.

Moorhouse, AD; Santos, AM; Gunaratnam, M; Moore, M; Neidle, S; Moses, JE; (2006) Stabilization of G-quadruplex DNA by highly selective ligands via click chemistry. J Am Chem Soc , 128 (50) pp. 15972-15973. 10.1021/ja0661919.

Moran, J; Verfuerth, S; Peggs, K; Mackinnon, S; (2006) Impact of CMV-specific immunotherapy on duration and cost of anti-viral therapy. In: BONE MARROW TRANSPLANTATION. (pp. S265 - S265). NATURE PUBLISHING GROUP